In the last 12 months, insiders at INTUITIVE SURGICAL INC ($ISRG) filed 1628 transactions with the SEC: 0 open-market purchases totaling $0 and 366 sales totaling $435,901,555. Net insider sentiment: net selling.
INTUITIVE SURGICAL INC operates in the Orthopedic, prosthetic & surgical appliances & supplies industry (Industrial Applications and Services sector).
Most Active Insiders
- GUTHART GARY S (CEO) — 56 transactions totaling $82,948,214
- MOHR MARSHALL (Executive VP Global Business S) — 62 transactions totaling $79,291,551
- GUTHART GARY S (Executive Chair of the Board o) — 17 transactions totaling $60,349,097
- Rosa David J. (President) — 64 transactions totaling $56,510,490
- Curet Myriam (EVP & Chief Medical Officer) — 161 transactions totaling $56,020,289
View all SEC Filings for INTUITIVE SURGICAL INC (ISRG).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | 1,152.0000 | 362,700,000 | 8.35% | 0.00% |
| March 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 105 | $229.39 | 514.0000 | 362,700,000 | 25.67% | 0.00% |
| March 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 105 | $493.95 | 409.0000 | 362,700,000 | 20.43% | 0.00% |
| March 9, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 645 | $485.01 | 1,613.0000 | 362,700,000 | 28.57% | 0.00% |
| March 6, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 648 | $490.19 | 2,258.0000 | 362,700,000 | 22.30% | 0.00% |
| March 3, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 648 | $488.10 | 5,916.0000 | 362,700,000 | 9.87% | 0.00% |
| March 5, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 648 | $495.20 | 2,906.0000 | 362,700,000 | 18.23% | 0.00% |
| March 4, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 2362 | $498.68 | 3,554.0000 | 362,700,000 | 39.93% | 0.00% |
| March 2, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 125 | $492.59 | 5,137.0000 | 362,700,000 | 2.38% | 0.00% |
| March 3, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 4728 | $487.18 | 409.0000 | 362,700,000 | 92.04% | 0.00% |
| March 2, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 125 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 27, 2026 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 249 | $499.71 | 909.0000 | 362,700,000 | 21.50% | 0.00% |
| Feb. 28, 2026 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 468 | $0.00 | 1,377.0000 | 362,700,000 | 51.49% | 0.00% |
| Feb. 28, 2026 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 233 | $503.51 | 1,144.0000 | 362,700,000 | 16.92% | 0.00% |
| March 3, 2026 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 118 | $487.18 | 1,026.0000 | 362,700,000 | 10.31% | 0.00% |
| Feb. 28, 2026 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 468 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Common Stock | 626 | $0.00 | 29,200.0000 | 362,700,000 | 2.19% | 0.00% |
| Feb. 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | F | Common Stock | 311 | $503.51 | 28,889.0000 | 362,700,000 | 1.07% | 0.00% |
| Feb. 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Common Stock | 8378 | $0.00 | 37,267.0000 | 362,700,000 | 29.00% | 0.00% |
| Feb. 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | F | Common Stock | 4155 | $503.51 | 33,112.0000 | 362,700,000 | 11.15% | 0.00% |
| Feb. 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Performance Stock Units - 2-28-2023 | 8378 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Restricted Stock Units - 2-28-2022 | 626 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | GUTHART GARY S | Director | M | Common Stock | 2506 | $0.00 | 1,275,087.0000 | 362,700,000 | 0.20% | 0.00% |
| Feb. 28, 2026 | GUTHART GARY S | Director | F | Common Stock | 1243 | $503.51 | 1,273,844.0000 | 362,700,000 | 0.10% | 0.00% |
| Feb. 28, 2026 | GUTHART GARY S | Director | M | Common Stock | 26334 | $0.00 | 1,300,178.0000 | 362,700,000 | 2.07% | 0.01% |
| Feb. 28, 2026 | GUTHART GARY S | Director | F | Common Stock | 13059 | $503.51 | 1,287,119.0000 | 362,700,000 | 1.00% | 0.00% |
| Feb. 28, 2026 | GUTHART GARY S | Director | M | Performance Stock Units - 2-28-2023 | 26334 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.01% |
| Feb. 28, 2026 | GUTHART GARY S | Director | M | Restricted Stock Units | 2506 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| March 2, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 125 | $208.90 | 5,262.0000 | 362,700,000 | 2.43% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 1503 | $0.00 | 234,151.0000 | 362,700,000 | 0.65% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | F | Common Stock | 746 | $503.51 | 233,405.0000 | 362,700,000 | 0.32% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 14363 | $0.00 | 247,768.0000 | 362,700,000 | 6.15% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | F | Common Stock | 7122 | $503.51 | 240,646.0000 | 362,700,000 | 2.87% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 9052 | $0.00 | 249,698.0000 | 362,700,000 | 3.76% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | F | Common Stock | 4489 | $503.51 | 245,209.0000 | 362,700,000 | 1.80% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Performance Stock Units - 2-28-2023 | 14363 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Performance Stock Units - 6-12-2023 | 9052 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Restricted Stock Units | 1503 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 877 | $0.00 | 2,776.0000 | 362,700,000 | 46.18% | 0.00% |
| Feb. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 435 | $503.51 | 2,341.0000 | 362,700,000 | 15.67% | 0.00% |
| Feb. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 8378 | $0.00 | 10,719.0000 | 362,700,000 | 357.88% | 0.00% |
| Feb. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 4155 | $503.51 | 6,564.0000 | 362,700,000 | 38.76% | 0.00% |
| Feb. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Performance Stock Units - 2-28-2023 | 8378 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-28-2022 | 877 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 3148 | $0.00 | 8,082.0000 | 362,700,000 | 63.80% | 0.00% |
| Feb. 28, 2026 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 1562 | $503.51 | 6,520.0000 | 362,700,000 | 19.33% | 0.00% |
| Feb. 28, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Performance Stock Units - 2-28-2023 | 3148 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 752 | $0.00 | 10,309.0000 | 362,700,000 | 7.87% | 0.00% |
| Feb. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 373 | $503.51 | 9,936.0000 | 362,700,000 | 3.62% | 0.00% |
| Feb. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 10773 | $0.00 | 20,709.0000 | 362,700,000 | 108.42% | 0.00% |
| Feb. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 5343 | $503.51 | 15,366.0000 | 362,700,000 | 25.80% | 0.00% |
| Feb. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Performance Stock Units - 2-28-2023 | 10773 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units | 752 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 4800 | $503.51 | 11,610.0000 | 362,700,000 | 29.25% | 0.00% |
| Feb. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 8378 | $0.00 | 9,292.0000 | 362,700,000 | 916.63% | 0.00% |
| Feb. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 497 | $503.51 | 914.0000 | 362,700,000 | 35.22% | 0.00% |
| Feb. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1002 | $0.00 | 1,411.0000 | 362,700,000 | 244.99% | 0.00% |
| Feb. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2345 | $499.71 | 409.0000 | 362,700,000 | 85.15% | 0.00% |
| Feb. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 10773 | $0.00 | 16,410.0000 | 362,700,000 | 191.11% | 0.00% |
| Feb. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 335 | $503.51 | 5,637.0000 | 362,700,000 | 5.61% | 0.00% |
| Feb. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 752 | $0.00 | 5,972.0000 | 362,700,000 | 14.41% | 0.00% |
| Feb. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1002 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Performance Stock Units - 2-28-2023 | 8378 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 4155 | $503.51 | 5,137.0000 | 362,700,000 | 44.72% | 0.00% |
| Feb. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Performance Stock Units - 2-28-2023 | 10773 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units | 752 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Restricted Stock Units - 2-26-2024 | 1526 | $0.00 | 3,052.0000 | 362,700,000 | 33.33% | 0.00% |
| Feb. 26, 2026 | WADORS PATRICIA L | SVP Chief Human Resources Offi | A | Restricted Stock Units - 2-26-2026 | 3584 | $0.00 | 3,584.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | WADORS PATRICIA L | SVP Chief Human Resources Offi | M | Restricted Stock Units - 2-26-2025 | 458 | $0.00 | 1,373.0000 | 362,700,000 | 25.01% | 0.00% |
| Feb. 27, 2026 | WADORS PATRICIA L | SVP Chief Human Resources Offi | S | Common Stock | 220 | $499.71 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 26, 2026 | WADORS PATRICIA L | SVP Chief Human Resources Offi | F | Common Stock | 238 | $506.17 | 220.0000 | 362,700,000 | 51.97% | 0.00% |
| Feb. 26, 2026 | WADORS PATRICIA L | SVP Chief Human Resources Offi | M | Common Stock | 458 | $0.00 | 458.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | A | Restricted Stock Units - 2-26-2026 | 1627 | $0.00 | 1,627.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units - 2-26-2025 | 378 | $0.00 | 1,133.0000 | 362,700,000 | 25.02% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units - 2-26-2024 | 611 | $0.00 | 1,220.0000 | 362,700,000 | 33.37% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 188 | $506.17 | 1,158.0000 | 362,700,000 | 13.97% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 378 | $0.00 | 1,346.0000 | 362,700,000 | 39.05% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 303 | $506.17 | 968.0000 | 362,700,000 | 23.84% | 0.00% |
| Feb. 26, 2026 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 611 | $0.00 | 1,271.0000 | 362,700,000 | 92.58% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units - 2-26-2025 | 1602 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units - 2-26-2024 | 3052 | $0.00 | 3,053.0000 | 362,700,000 | 49.99% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | A | Performance Stock Units - 2-28-2023 | 2793 | $0.00 | 8,378.0000 | 362,700,000 | 50.01% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 795 | $506.17 | 2,754.0000 | 362,700,000 | 22.40% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 3816 | $0.00 | 233,386.0000 | 362,700,000 | 1.66% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | F | Common Stock | 1892 | $506.17 | 231,494.0000 | 362,700,000 | 0.81% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 2289 | $0.00 | 233,783.0000 | 362,700,000 | 0.99% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | F | Common Stock | 1135 | $506.17 | 232,648.0000 | 362,700,000 | 0.49% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | A | Performance Stock Units - 2-28-2023 | 4788 | $0.00 | 14,363.0000 | 362,700,000 | 50.01% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | A | Performance Stock Units - 6-12-2023 | 3018 | $0.00 | 9,052.0000 | 362,700,000 | 50.02% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Restricted Stock Units - 2-26-2024 | 3816 | $0.00 | 7,631.0000 | 362,700,000 | 33.34% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Restricted Stock Units - 2-26-2025 | 2289 | $0.00 | 6,866.0000 | 362,700,000 | 25.00% | 0.00% |
| Feb. 26, 2026 | Rosa David J. | Chief Executive Officer (CEO) | A | Restricted Stock Units - 2-26-2026 | 13441 | $0.00 | 13,441.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | M | Common Stock | 4960 | $0.00 | 1,273,311.0000 | 362,700,000 | 0.39% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | F | Common Stock | 2460 | $506.17 | 1,270,851.0000 | 362,700,000 | 0.19% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | M | Common Stock | 3433 | $0.00 | 1,274,284.0000 | 362,700,000 | 0.27% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | F | Common Stock | 1703 | $506.17 | 1,272,581.0000 | 362,700,000 | 0.13% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | A | Performance Stock Units - 2-28-2023 | 8778 | $0.00 | 26,334.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | M | Restricted Stock Units - 2-26-2024 | 4960 | $0.00 | 9,920.0000 | 362,700,000 | 33.33% | 0.00% |
| Feb. 26, 2026 | GUTHART GARY S | Director | M | Restricted Stock Units - 2-26-2025 | 3433 | $0.00 | 10,299.0000 | 362,700,000 | 25.00% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 1622 | $0.00 | 2,214.0000 | 362,700,000 | 273.99% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 805 | $506.17 | 1,409.0000 | 362,700,000 | 36.36% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 973 | $0.00 | 2,382.0000 | 362,700,000 | 69.06% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 483 | $506.17 | 1,899.0000 | 362,700,000 | 20.28% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Performance Stock Units - 2-28-2023 | 2793 | $0.00 | 8,378.0000 | 362,700,000 | 50.01% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-26-2024 | 1622 | $0.00 | 3,243.0000 | 362,700,000 | 33.34% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-26-2025 | 973 | $0.00 | 2,918.0000 | 362,700,000 | 25.01% | 0.00% |
| Feb. 26, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Restricted Stock Units - 2-26-2026 | 4928 | $0.00 | 4,928.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Common Stock | 1622 | $0.00 | 28,856.0000 | 362,700,000 | 5.96% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | F | Common Stock | 631 | $506.17 | 28,225.0000 | 362,700,000 | 2.19% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Common Stock | 687 | $0.00 | 28,912.0000 | 362,700,000 | 2.43% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | F | Common Stock | 341 | $506.17 | 28,571.0000 | 362,700,000 | 1.18% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | A | Performance Stock Units - 2-28-2023 | 2793 | $0.00 | 8,378.0000 | 362,700,000 | 50.01% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Restricted Stock Units - 2-26-2024 | 1622 | $0.00 | 3,243.0000 | 362,700,000 | 33.34% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Restricted Stock Units - 2-26-2025 | 687 | $0.00 | 2,059.0000 | 362,700,000 | 25.02% | 0.00% |
| Feb. 26, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | A | Restricted Stock Units - 2-26-2026 | 4480 | $0.00 | 4,480.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 1717 | $0.00 | 5,414.0000 | 362,700,000 | 46.44% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 765 | $506.17 | 4,649.0000 | 362,700,000 | 14.13% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 1030 | $0.00 | 5,679.0000 | 362,700,000 | 22.16% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 459 | $506.17 | 5,220.0000 | 362,700,000 | 8.08% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | A | Performance Stock Units - 2-28-2023 | 3591 | $0.00 | 10,773.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units - 2-26-2024 | 1717 | $0.00 | 3,434.0000 | 362,700,000 | 33.33% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units - 2-26-2025 | 1030 | $0.00 | 3,090.0000 | 362,700,000 | 25.00% | 0.00% |
| Feb. 26, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | A | Restricted Stock Units - 2-26-2026 | 4032 | $0.00 | 4,032.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 1908 | $0.00 | 9,707.0000 | 362,700,000 | 24.46% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 900 | $506.17 | 8,807.0000 | 362,700,000 | 9.27% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 1488 | $0.00 | 10,295.0000 | 362,700,000 | 16.90% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 738 | $506.17 | 9,557.0000 | 362,700,000 | 7.17% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | A | Performance Stock Units - 2-28-2023 | 3591 | $0.00 | 10,773.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units - 2-26-2024 | 1908 | $0.00 | 3,815.0000 | 362,700,000 | 33.34% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units - 2-26-2025 | 1488 | $0.00 | 4,463.0000 | 362,700,000 | 25.00% | 0.00% |
| Feb. 26, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | A | Restricted Stock Units - 2-26-2026 | 6720 | $0.00 | 6,720.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 1526 | $0.00 | 5,230.0000 | 362,700,000 | 41.20% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 757 | $506.17 | 4,473.0000 | 362,700,000 | 14.47% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 916 | $0.00 | 5,389.0000 | 362,700,000 | 20.48% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 455 | $506.17 | 4,934.0000 | 362,700,000 | 8.44% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | A | Performance Stock Units - 2-28-2023 | 1050 | $0.00 | 3,148.0000 | 362,700,000 | 50.05% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Restricted Stock Units - 2-26-2025 | 916 | $0.00 | 2,746.0000 | 362,700,000 | 25.01% | 0.00% |
| Feb. 26, 2026 | LOEB GARY | EVP & Chief Legal and Complian | A | Restricted Stock Units - 2-26-2026 | 3584 | $0.00 | 3,584.0000 | 362,700,000 | 9999.99% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 3052 | $0.00 | 3,461.0000 | 362,700,000 | 746.21% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 1514 | $506.17 | 1,947.0000 | 362,700,000 | 43.74% | 0.00% |
| Feb. 26, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1602 | $0.00 | 3,549.0000 | 362,700,000 | 82.28% | 0.00% |
| Feb. 11, 2026 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 133 | $494.96 | 660.0000 | 362,700,000 | 16.77% | 0.00% |
| Feb. 10, 2026 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 567 | $0.00 | 567.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 838 | $0.00 | 838.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 838 | $0.00 | 1,247.0000 | 362,700,000 | 204.89% | 0.00% |
| Feb. 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | 1,257.0000 | 362,700,000 | 7.71% | 0.00% |
| Feb. 10, 2026 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 567 | $0.00 | 1,095.0000 | 362,700,000 | 107.39% | 0.00% |
| Feb. 11, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 421 | $494.96 | 409.0000 | 362,700,000 | 50.72% | 0.00% |
| Feb. 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 105 | $494.65 | 830.0000 | 362,700,000 | 11.23% | 0.00% |
| Feb. 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 105 | $229.39 | 935.0000 | 362,700,000 | 12.65% | 0.00% |
| Feb. 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 417 | $492.84 | 830.0000 | 362,700,000 | 33.44% | 0.00% |
| Feb. 10, 2026 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 302 | $492.84 | 793.0000 | 362,700,000 | 27.58% | 0.00% |
| Feb. 10, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 492 | $492.84 | 3,697.0000 | 362,700,000 | 11.75% | 0.00% |
| Feb. 10, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units | 1077 | $0.00 | 1,077.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 838 | $0.00 | 1,025.0000 | 362,700,000 | 448.13% | 0.00% |
| Feb. 10, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 433 | $492.84 | 592.0000 | 362,700,000 | 42.24% | 0.00% |
| Feb. 10, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-28-2023 | 838 | $0.00 | 838.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 1436 | $0.00 | 230,294.0000 | 362,700,000 | 0.63% | 0.00% |
| Feb. 10, 2026 | Rosa David J. | Chief Executive Officer (CEO) | F | Common Stock | 724 | $492.84 | 229,570.0000 | 362,700,000 | 0.31% | 0.00% |
| Feb. 10, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | Restricted Stock Units - 2-28-2023 | 1436 | $0.00 | 1,436.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | GUTHART GARY S | Director | M | Common Stock | 2633 | $0.00 | 1,269,657.0000 | 362,700,000 | 0.21% | 0.00% |
| Feb. 10, 2026 | GUTHART GARY S | Director | F | Common Stock | 1306 | $492.84 | 1,268,351.0000 | 362,700,000 | 0.10% | 0.00% |
| Feb. 10, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Restricted Stock Units | 315 | $0.00 | 314.0000 | 362,700,000 | 50.08% | 0.00% |
| Feb. 10, 2026 | GUTHART GARY S | Director | M | Restricted Stock Units | 2633 | $0.00 | 2,633.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 315 | $0.00 | 3,876.0000 | 362,700,000 | 8.85% | 0.00% |
| Feb. 10, 2026 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 172 | $492.84 | 3,704.0000 | 362,700,000 | 4.44% | 0.00% |
| Feb. 10, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Common Stock | 838 | $0.00 | 27,543.0000 | 362,700,000 | 3.14% | 0.00% |
| Feb. 10, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | F | Common Stock | 309 | $492.84 | 27,234.0000 | 362,700,000 | 1.12% | 0.00% |
| Feb. 10, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | Restricted Stock Units - 2-28-2023 | 838 | $0.00 | 838.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 1077 | $0.00 | 8,295.0000 | 362,700,000 | 14.92% | 0.00% |
| Feb. 10, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 496 | $492.84 | 7,799.0000 | 362,700,000 | 5.98% | 0.00% |
| Feb. 10, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units | 1077 | $0.00 | 1,077.0000 | 362,700,000 | 50.00% | 0.00% |
| Feb. 10, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 1077 | $0.00 | 4,189.0000 | 362,700,000 | 34.61% | 0.00% |
| Jan. 28, 2026 | LOEB GARY | EVP & Chief Legal and Complian | A | Performance Stock Units - 2-28-2023 | 2098 | $0.00 | 2,098.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Performance Stock Units - 2-28-2023 | 5585 | $0.00 | 5,585.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Performance Stock Units - 2-26-2024 | 2702 | $0.00 | 2,702.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | Leonard Keith R | Director | J | Common Stock | 369 | $0.00 | 370.0000 | 362,700,000 | 49.93% | 0.00% |
| Jan. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | A | Performance Stock Units - 2-28-2023 | 7182 | $0.00 | 7,182.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Samath Jamie | EVP & CFO & Enterprise Technol | A | Performance Stock Units - 2-26-2024 | 3180 | $0.00 | 3,180.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | A | Performance Stock Units - 2-28-2023 | 7182 | $0.00 | 7,182.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Charlton Henry L | EVP & Chief Commercial and Mkt | A | Performance Stock Units - 2-26-2024 | 2861 | $0.00 | 2,861.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | GUTHART GARY S | Director | A | Performance Stock Units - 2-28-2023 | 17556 | $0.00 | 17,556.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | GUTHART GARY S | Director | A | Performance Stock Units - 2-26-2024 | 8267 | $0.00 | 8,267.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | A | Performance Stock Units - 2-28-2023 | 5585 | $0.00 | 5,585.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 126 | $0.00 | 125.0000 | 362,700,000 | 50.20% | 0.00% |
| Jan. 29, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 126 | $520.02 | 353.0000 | 362,700,000 | 26.30% | 0.00% |
| Jan. 29, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 126 | $208.90 | 479.0000 | 362,700,000 | 35.69% | 0.00% |
| Jan. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | A | Performance Stock Units - 6-12-2023 | 6034 | $0.00 | 6,034.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | A | Performance Stock Units - 2-28-2023 | 9575 | $0.00 | 9,575.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | A | Performance Stock Units - 2-26-2024 | 6360 | $0.00 | 6,360.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 28, 2026 | LOEB GARY | EVP & Chief Legal and Complian | A | Performance Stock Units - 2-26-2024 | 2543 | $0.00 | 2,543.0000 | 362,700,000 | 9999.99% | 0.00% |
| Jan. 27, 2026 | GUTHART GARY S | Director | M | Non-Qualified Stock Option (right to buy) | 25500 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.01% |
| Jan. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 105 | $532.61 | 353.0000 | 362,700,000 | 22.93% | 0.00% |
| Jan. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 125 | $208.90 | 478.0000 | 362,700,000 | 35.41% | 0.00% |
| Jan. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 125 | $532.61 | 353.0000 | 362,700,000 | 26.15% | 0.00% |
| Jan. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 125 | $0.00 | 251.0000 | 362,700,000 | 33.24% | 0.00% |
| Jan. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 105 | $229.39 | 458.0000 | 362,700,000 | 29.75% | 0.00% |
| Jan. 27, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | 1,362.0000 | 362,700,000 | 7.16% | 0.00% |
| Jan. 27, 2026 | GUTHART GARY S | Director | M | Common Stock | 25500 | $174.26 | 1,291,524.0000 | 362,700,000 | 2.01% | 0.01% |
| Jan. 27, 2026 | GUTHART GARY S | Director | S | Common Stock | 24500 | $530.10 | 1,267,024.0000 | 362,700,000 | 1.90% | 0.01% |
| Jan. 27, 2026 | GUTHART GARY S | Director | S | Common Stock | 1400 | $531.53 | 1,267,024.0000 | 362,700,000 | 0.11% | 0.00% |
| Jan. 27, 2026 | GUTHART GARY S | Director | S | Common Stock | 1400 | $531.52 | 1,267,024.0000 | 362,700,000 | 0.11% | 0.00% |
| Dec. 12, 2025 | Brosius Mark | See Remarks | S | Common Stock | 312 | $547.36 | 595.0000 | 363,500,000 | 34.40% | 0.00% |
| Dec. 15, 2025 | Brosius Mark | See Remarks | S | Common Stock | 464 | $548.49 | 131.0000 | 363,500,000 | 77.98% | 0.00% |
| Dec. 15, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 464 | $548.49 | 443.0000 | 363,500,000 | 51.16% | 0.00% |
| Dec. 12, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 4500 | $79.64 | 5,407.0000 | 363,500,000 | 496.14% | 0.00% |
| Dec. 12, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 4500 | $547.36 | 907.0000 | 363,500,000 | 83.23% | 0.00% |
| Dec. 12, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Non-Qualified Stock Option (right to buy) | 4500 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Dec. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 104 | $0.00 | 1,467.0000 | 363,500,000 | 6.62% | 0.00% |
| Dec. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 104 | $229.39 | 457.0000 | 363,500,000 | 29.46% | 0.00% |
| Dec. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 104 | $559.90 | 353.0000 | 363,500,000 | 22.76% | 0.00% |
| Dec. 1, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Non-Qualified Stock Option (right to buy) | 25500 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.01% |
| Dec. 1, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 125 | $208.90 | 478.0000 | 363,500,000 | 35.41% | 0.00% |
| Dec. 1, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 125 | $0.00 | 376.0000 | 363,500,000 | 24.95% | 0.00% |
| Dec. 1, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 125 | $568.99 | 353.0000 | 363,500,000 | 26.15% | 0.00% |
| Dec. 1, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 22806 | $570.89 | 1,268,824.0000 | 363,500,000 | 1.77% | 0.01% |
| Dec. 1, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Common Stock | 25500 | $139.52 | 1,291,630.0000 | 363,500,000 | 2.01% | 0.01% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 2898 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Nov. 12, 2025 | Leonard Keith R | Director | G | Common Stock | 1606 | $0.00 | 739.0000 | 363,500,000 | 68.49% | 0.00% |
| Nov. 12, 2025 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 750 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Nov. 12, 2025 | BARRATT CRAIG H | Director | S | Common Stock | 750 | $580.00 | 27,198.0000 | 363,500,000 | 2.68% | 0.00% |
| Nov. 12, 2025 | BARRATT CRAIG H | Director | M | Common Stock | 750 | $71.32 | 27,948.0000 | 363,500,000 | 2.76% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 636 | $0.00 | 1,929.0000 | 363,500,000 | 24.80% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 2565 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 2901 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | S | Common Stock | 4731 | $580.00 | 3,056.0000 | 363,500,000 | 60.76% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | S | Common Stock | 2901 | $580.00 | 7,787.0000 | 363,500,000 | 27.14% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 2901 | $177.99 | 10,688.0000 | 363,500,000 | 37.25% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | S | Common Stock | 2898 | $580.00 | 7,787.0000 | 363,500,000 | 27.12% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 636 | $347.42 | 8,423.0000 | 363,500,000 | 8.17% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | S | Common Stock | 636 | $580.00 | 7,787.0000 | 363,500,000 | 7.55% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 2565 | $245.60 | 10,352.0000 | 363,500,000 | 32.94% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | S | Common Stock | 2565 | $580.00 | 7,787.0000 | 363,500,000 | 24.78% | 0.00% |
| Nov. 12, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 2898 | $242.34 | 10,685.0000 | 363,500,000 | 37.22% | 0.00% |
| Nov. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 2202 | $208.90 | 7,960.0000 | 363,500,000 | 38.24% | 0.00% |
| Nov. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 1298 | $575.00 | 5,758.0000 | 363,500,000 | 18.40% | 0.00% |
| Nov. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1298 | $229.39 | 7,056.0000 | 363,500,000 | 22.54% | 0.00% |
| Nov. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 105 | $229.39 | 458.0000 | 363,500,000 | 29.75% | 0.00% |
| Nov. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 105 | $560.00 | 353.0000 | 363,500,000 | 22.93% | 0.00% |
| Nov. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | 1,571.0000 | 363,500,000 | 6.26% | 0.00% |
| Nov. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Non-Qualified Stock Option (right to buy) | 1298 | $0.00 | 6,602.0000 | 363,500,000 | 16.43% | 0.00% |
| Nov. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 2202 | $575.00 | 5,758.0000 | 363,500,000 | 27.66% | 0.00% |
| Nov. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Non-Qualified Stock Option (right to buy) | 2202 | $0.00 | 2,115.0000 | 363,500,000 | 51.01% | 0.00% |
| Nov. 5, 2025 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 1908 | $550.00 | 473.0000 | 363,500,000 | 80.13% | 0.00% |
| Nov. 5, 2025 | Widman Fredrik | VP Corporate Controller | M | Non-Qualified Stock Option (right to buy) | 1908 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Nov. 5, 2025 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 159 | $59.46 | 632.0000 | 363,500,000 | 33.62% | 0.00% |
| Nov. 5, 2025 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 159 | $550.00 | 473.0000 | 363,500,000 | 25.16% | 0.00% |
| Nov. 5, 2025 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 1908 | $77.00 | 2,381.0000 | 363,500,000 | 403.38% | 0.00% |
| Nov. 5, 2025 | Widman Fredrik | VP Corporate Controller | M | Non-Qualified Stock Option (right to buy) | 159 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Nov. 3, 2025 | Rosa David J. | Chief Executive Officer (CEO) | G | Common Stock | 5454 | $0.00 | 228,802.0000 | 363,500,000 | 2.33% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1379 | $208.90 | 2,085.0000 | 363,500,000 | 195.33% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 5030 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 1153 | $0.00 | 1,676.0000 | 363,500,000 | 40.76% | 0.00% |
| Oct. 29, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 125 | $0.00 | 501.0000 | 363,500,000 | 19.97% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 1379 | $0.00 | 626.0000 | 363,500,000 | 68.78% | 0.00% |
| Oct. 29, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 125 | $543.00 | 353.0000 | 363,500,000 | 26.15% | 0.00% |
| Oct. 29, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 125 | $208.90 | 478.0000 | 363,500,000 | 35.41% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 5030 | $242.34 | 5,736.0000 | 363,500,000 | 712.46% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 5030 | $548.43 | 706.0000 | 363,500,000 | 87.69% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1153 | $229.39 | 1,859.0000 | 363,500,000 | 163.31% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1153 | $548.43 | 706.0000 | 363,500,000 | 62.02% | 0.00% |
| Oct. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1379 | $548.43 | 706.0000 | 363,500,000 | 66.14% | 0.00% |
| Oct. 24, 2025 | BARRATT CRAIG H | Director | S | Common Stock | 2193 | $548.01 | 27,198.0000 | 363,500,000 | 7.46% | 0.00% |
| Oct. 24, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 1400 | $546.18 | 1,266,130.0000 | 363,500,000 | 0.11% | 0.00% |
| Oct. 24, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 1400 | $546.35 | 1,266,130.0000 | 363,500,000 | 0.11% | 0.00% |
| Oct. 24, 2025 | Rosa David J. | Chief Executive Officer (CEO) | M | Common Stock | 27000 | $79.64 | 258,756.0000 | 363,500,000 | 11.65% | 0.01% |
| Oct. 24, 2025 | Rosa David J. | Chief Executive Officer (CEO) | S | Common Stock | 24500 | $547.55 | 234,256.0000 | 363,500,000 | 9.47% | 0.01% |
| Oct. 24, 2025 | Rosa David J. | Chief Executive Officer (CEO) | M | Non-Qualified Stock Option (right to buy) | 27000 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.01% |
| Oct. 24, 2025 | BARRATT CRAIG H | Director | M | Common Stock | 2193 | $71.32 | 29,391.0000 | 363,500,000 | 8.06% | 0.00% |
| Oct. 24, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Non-Qualified Stock Option (right to buy) | 36000 | $0.00 | 0.0000 | 363,500,000 | 100.00% | 0.01% |
| Oct. 24, 2025 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 2193 | $0.00 | 750.0000 | 363,500,000 | 74.52% | 0.00% |
| Oct. 24, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Common Stock | 36000 | $109.49 | 1,294,930.0000 | 363,500,000 | 2.86% | 0.01% |
| Oct. 24, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 28800 | $547.56 | 1,266,130.0000 | 363,500,000 | 2.22% | 0.01% |
| Oct. 10, 2025 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 1296 | $443.76 | 3,561.0000 | 363,500,000 | 26.68% | 0.00% |
| Oct. 10, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 2612 | $0.00 | 4,857.0000 | 363,500,000 | 116.35% | 0.00% |
| Oct. 10, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Restricted Stock Units | 2612 | $0.00 | 2,612.0000 | 363,500,000 | 50.00% | 0.00% |
| Sept. 3, 2025 | Ladd Amy L | Director | S | Common Stock | 336 | $470.11 | 1,074.0000 | 362,000,000 | 23.83% | 0.00% |
| Sept. 4, 2025 | Ladd Amy L | Director | S | Common Stock | 335 | $440.69 | 739.0000 | 362,000,000 | 31.19% | 0.00% |
| Aug. 29, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 29360 | $472.49 | 1,261,730.0000 | 362,000,000 | 2.27% | 0.01% |
| Aug. 29, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Common Stock | 36000 | $79.64 | 1,291,090.0000 | 362,000,000 | 2.87% | 0.01% |
| Aug. 29, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Non-Qualified Stock Option (right to buy) | 36000 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.01% |
| July 28, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 1400 | $495.24 | 1,255,090.0000 | 362,000,000 | 0.11% | 0.00% |
| July 28, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 1400 | $495.23 | 1,255,090.0000 | 362,000,000 | 0.11% | 0.00% |
| July 28, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Common Stock | 7893 | $59.46 | 1,262,983.0000 | 362,000,000 | 0.63% | 0.00% |
| July 28, 2025 | GUTHART GARY S | Executive Chair of the Board o | S | Common Stock | 7893 | $498.64 | 1,255,090.0000 | 362,000,000 | 0.62% | 0.00% |
| July 28, 2025 | GUTHART GARY S | Executive Chair of the Board o | M | Non-Qualified Stock Option (right to buy) | 7893 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| July 28, 2025 | GUTHART GARY S | Executive Chair of the Board o | G | Common Stock | 10500 | $0.00 | 1,255,090.0000 | 362,000,000 | 0.83% | 0.00% |
| July 25, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 4500 | $0.00 | 5,030.0000 | 362,000,000 | 47.22% | 0.00% |
| July 25, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 4500 | $492.48 | 353.0000 | 362,000,000 | 92.73% | 0.00% |
| July 25, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 4500 | $242.34 | 4,853.0000 | 362,000,000 | 1274.79% | 0.00% |
| July 10, 2025 | Rosa David J. | Chief Executive Officer (CEO) | A | Restricted Stock Units | 7640 | $0.00 | 7,640.0000 | 362,000,000 | 9999.99% | 0.00% |
| June 10, 2025 | Rosa David J. | President | M | Common Stock | 1358 | $0.00 | 232,430.0000 | 362,000,000 | 0.59% | 0.00% |
| June 10, 2025 | Rosa David J. | President | M | Restricted Stock Units - 6-12-23 | 1358 | $0.00 | 2,716.0000 | 362,000,000 | 33.33% | 0.00% |
| June 10, 2025 | Rosa David J. | President | F | Common Stock | 674 | $526.15 | 231,756.0000 | 362,000,000 | 0.29% | 0.00% |
| June 5, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 215 | $560.70 | 1,123.0000 | 362,000,000 | 16.07% | 0.00% |
| June 6, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 216 | $563.11 | 907.0000 | 362,000,000 | 19.23% | 0.00% |
| June 4, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 215 | $552.07 | 1,338.0000 | 362,000,000 | 13.84% | 0.00% |
| June 4, 2025 | Rosa David J. | President | G | Common Stock | 851 | $0.00 | 231,072.0000 | 362,000,000 | 0.37% | 0.00% |
| June 2, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 215 | $549.06 | 1,768.0000 | 362,000,000 | 10.84% | 0.00% |
| June 3, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 215 | $550.68 | 1,553.0000 | 362,000,000 | 12.16% | 0.00% |
| May 15, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $560.00 | 2,003.0000 | 362,000,000 | 1.09% | 0.00% |
| May 16, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 20 | $563.81 | 1,983.0000 | 362,000,000 | 1.00% | 0.00% |
| May 13, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $561.67 | 2,047.0000 | 362,000,000 | 1.06% | 0.00% |
| May 12, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $551.97 | 2,069.0000 | 362,000,000 | 1.05% | 0.00% |
| May 14, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $563.00 | 2,025.0000 | 362,000,000 | 1.07% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 940.0000 | 362,000,000 | 16.67% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Common Stock | 188 | $208.90 | 7,350.0000 | 362,000,000 | 2.62% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Common Stock | 269 | $229.39 | 7,619.0000 | 362,000,000 | 3.66% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Common Stock | 188 | $290.33 | 7,807.0000 | 362,000,000 | 2.47% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Common Stock | 270 | $304.67 | 8,077.0000 | 362,000,000 | 3.46% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | S | Common Stock | 915 | $527.95 | 7,162.0000 | 362,000,000 | 11.33% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 940.0000 | 362,000,000 | 16.67% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 269 | $0.00 | 2,963.0000 | 362,000,000 | 8.32% | 0.00% |
| May 2, 2025 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 270 | $0.00 | 2,962.0000 | 362,000,000 | 8.35% | 0.00% |
| May 1, 2025 | Kolli Sreelakshmi | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Common Stock | 1709 | $295.92 | 3,119.0000 | 362,000,000 | 121.21% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | S | Common Stock | 1709 | $505.55 | 1,410.0000 | 362,000,000 | 54.79% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Non-Qualified Stock Option (right to buy) | 2298 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Non-Qualified Stock Option (right to buy) | 1650 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Non-Qualified Stock Option (right to buy) | 1448 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Non-Qualified Stock Option (right to buy) | 1671 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| May 1, 2025 | Ladd Amy L | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Reed Monica P | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | NACHTSHEIM JAMI K | Director | M | Common Stock | 2400 | $90.49 | 8,771.0000 | 362,000,000 | 37.67% | 0.00% |
| May 1, 2025 | NACHTSHEIM JAMI K | Director | S | Common Stock | 2400 | $520.00 | 6,371.0000 | 362,000,000 | 27.36% | 0.00% |
| May 1, 2025 | NACHTSHEIM JAMI K | Director | M | Non-Qualified Stock Option (right to buy) | 2400 | $0.00 | 2,235.0000 | 362,000,000 | 51.78% | 0.00% |
| May 1, 2025 | NACHTSHEIM JAMI K | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Leonard Keith R | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Johnson Amal M | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | CHEW LEWIS | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Beery Joseph C | Director | A | Restricted Stock Units | 531 | $0.00 | 531.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | BARRATT CRAIG H | Director | A | Restricted Stock Units | 750 | $0.00 | 750.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Common Stock | 1448 | $243.26 | 2,858.0000 | 362,000,000 | 102.70% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | S | Common Stock | 1448 | $505.55 | 1,410.0000 | 362,000,000 | 50.66% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Common Stock | 1671 | $286.55 | 3,081.0000 | 362,000,000 | 118.51% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | S | Common Stock | 1671 | $505.55 | 1,410.0000 | 362,000,000 | 54.24% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Common Stock | 2298 | $171.07 | 3,708.0000 | 362,000,000 | 162.98% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | S | Common Stock | 2298 | $505.55 | 1,410.0000 | 362,000,000 | 61.97% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | M | Common Stock | 1650 | $171.20 | 3,060.0000 | 362,000,000 | 117.02% | 0.00% |
| April 30, 2025 | Ladd Amy L | Director | S | Common Stock | 1650 | $505.55 | 1,410.0000 | 362,000,000 | 53.92% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 2,634.0000 | 362,000,000 | 4.32% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,412.0000 | 362,000,000 | 3.60% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $513.18 | 5,224.0000 | 362,000,000 | 3.47% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $304.67 | 5,343.0000 | 362,000,000 | 2.28% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $513.18 | 5,224.0000 | 362,000,000 | 2.23% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $229.39 | 5,343.0000 | 362,000,000 | 2.28% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $513.18 | 5,224.0000 | 362,000,000 | 2.23% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,412.0000 | 362,000,000 | 3.60% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $513.18 | 5,224.0000 | 362,000,000 | 3.47% | 0.00% |
| April 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,412.0000 | 362,000,000 | 3.60% | 0.00% |
| April 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $515.91 | 5,224.0000 | 362,000,000 | 3.47% | 0.00% |
| April 29, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,412.0000 | 362,000,000 | 3.60% | 0.00% |
| April 29, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $512.90 | 5,224.0000 | 362,000,000 | 3.47% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 2,068.0000 | 362,000,000 | 8.33% | 0.00% |
| April 29, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 1,880.0000 | 362,000,000 | 9.09% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 2,634.0000 | 362,000,000 | 4.32% | 0.00% |
| April 25, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 2,068.0000 | 362,000,000 | 8.33% | 0.00% |
| April 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 1,880.0000 | 362,000,000 | 9.09% | 0.00% |
| April 25, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 4000 | $513.18 | 353.0000 | 362,000,000 | 91.89% | 0.00% |
| April 25, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 4000 | $242.34 | 4,353.0000 | 362,000,000 | 1133.14% | 0.00% |
| April 25, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 4000 | $0.00 | 9,530.0000 | 362,000,000 | 29.56% | 0.00% |
| April 25, 2025 | Leonard Keith R | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | LOEB GARY | EVP & Chief Legal and Complian | S | Common Stock | 1700 | $513.18 | 2,245.0000 | 362,000,000 | 43.09% | 0.00% |
| April 25, 2025 | NACHTSHEIM JAMI K | Director | M | Common Stock | 739 | $0.00 | 6,371.0000 | 362,000,000 | 13.12% | 0.00% |
| April 25, 2025 | NACHTSHEIM JAMI K | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | CHEW LEWIS | Director | M | Common Stock | 739 | $0.00 | 783.0000 | 362,000,000 | 1679.55% | 0.00% |
| April 25, 2025 | CHEW LEWIS | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | Johnson Amal M | Director | M | Common Stock | 739 | $0.00 | 13,014.0000 | 362,000,000 | 6.02% | 0.00% |
| April 25, 2025 | Johnson Amal M | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | Reed Monica P | Director | M | Common Stock | 739 | $0.00 | 2,345.0000 | 362,000,000 | 46.01% | 0.00% |
| April 25, 2025 | Reed Monica P | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | BARRATT CRAIG H | Director | M | Common Stock | 1043 | $0.00 | 27,198.0000 | 362,000,000 | 3.99% | 0.00% |
| April 25, 2025 | BARRATT CRAIG H | Director | M | Restricted Stock Units | 1043 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | Ladd Amy L | Director | M | Common Stock | 739 | $0.00 | 1,410.0000 | 362,000,000 | 110.13% | 0.00% |
| April 25, 2025 | Ladd Amy L | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | Kolli Sreelakshmi | Director | M | Common Stock | 739 | $0.00 | 979.0000 | 362,000,000 | 307.92% | 0.00% |
| April 25, 2025 | Kolli Sreelakshmi | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | Leonard Keith R | Director | M | Common Stock | 739 | $0.00 | 2,345.0000 | 362,000,000 | 46.01% | 0.00% |
| April 25, 2025 | RUBASH MARK J | Director | M | Common Stock | 739 | $0.00 | 16,790.0000 | 362,000,000 | 4.60% | 0.00% |
| April 25, 2025 | RUBASH MARK J | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 25, 2025 | Beery Joseph C | Director | M | Common Stock | 739 | $0.00 | 3,110.0000 | 362,000,000 | 31.17% | 0.00% |
| April 25, 2025 | Beery Joseph C | Director | M | Restricted Stock Units | 739 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 479 | $0.00 | 2,753.0000 | 362,000,000 | 14.82% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 564 | $290.33 | 14,052.0000 | 362,000,000 | 4.18% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 564 | $498.71 | 13,488.0000 | 362,000,000 | 4.01% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 597 | $347.42 | 14,085.0000 | 362,000,000 | 4.43% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 597 | $498.71 | 13,488.0000 | 362,000,000 | 4.24% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 597 | $245.60 | 14,085.0000 | 362,000,000 | 4.43% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 597 | $498.71 | 13,488.0000 | 362,000,000 | 4.24% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 479 | $304.67 | 13,967.0000 | 362,000,000 | 3.55% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 479 | $498.71 | 13,488.0000 | 362,000,000 | 3.43% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 480 | $229.39 | 13,968.0000 | 362,000,000 | 3.56% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 480 | $498.71 | 13,488.0000 | 362,000,000 | 3.44% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 564 | $208.90 | 14,052.0000 | 362,000,000 | 4.18% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 564 | $498.71 | 13,488.0000 | 362,000,000 | 4.01% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 3707 | $498.71 | 9,781.0000 | 362,000,000 | 27.48% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 4557 | $500.00 | 5,224.0000 | 362,000,000 | 46.59% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 564 | $0.00 | 2,256.0000 | 362,000,000 | 20.00% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 597 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 480 | $0.00 | 2,753.0000 | 362,000,000 | 14.85% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 597 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| March 13, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 564 | $0.00 | 2,256.0000 | 362,000,000 | 20.00% | 0.00% |
| March 11, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Non-Qualified Stock Option (right to buy) | 1834 | $0.00 | 1,550.0000 | 362,000,000 | 54.20% | 0.00% |
| March 12, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Non-Qualified Stock Option (right to buy) | 2450 | $0.00 | 4,317.0000 | 362,000,000 | 36.21% | 0.00% |
| March 12, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Non-Qualified Stock Option (right to buy) | 1550 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| March 12, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 2450 | $512.06 | 5,758.0000 | 362,000,000 | 29.85% | 0.00% |
| March 12, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 2450 | $208.90 | 8,208.0000 | 362,000,000 | 42.55% | 0.00% |
| March 12, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 1550 | $512.06 | 5,758.0000 | 362,000,000 | 21.21% | 0.00% |
| March 12, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1550 | $177.99 | 7,308.0000 | 362,000,000 | 26.92% | 0.00% |
| March 11, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 6624 | $484.97 | 5,758.0000 | 362,000,000 | 53.50% | 0.00% |
| March 11, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 442 | $482.82 | 12,382.0000 | 362,000,000 | 3.45% | 0.00% |
| March 11, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 1834 | $485.96 | 12,824.0000 | 362,000,000 | 12.51% | 0.00% |
| March 11, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1834 | $177.99 | 14,658.0000 | 362,000,000 | 14.30% | 0.00% |
| March 7, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 489 | $533.18 | 2,091.0000 | 362,000,000 | 18.95% | 0.00% |
| March 5, 2025 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 14625 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| March 4, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 492 | $563.69 | 3,564.0000 | 362,000,000 | 12.13% | 0.00% |
| March 5, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 492 | $554.17 | 3,072.0000 | 362,000,000 | 13.80% | 0.00% |
| March 6, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 492 | $558.95 | 2,580.0000 | 362,000,000 | 16.02% | 0.00% |
| March 5, 2025 | Rosa David J. | President | M | Common Stock | 14625 | $77.00 | 233,807.0000 | 362,000,000 | 6.67% | 0.00% |
| March 5, 2025 | Rosa David J. | President | S | Common Stock | 8369 | $557.47 | 225,438.0000 | 362,000,000 | 3.58% | 0.00% |
| March 5, 2025 | Rosa David J. | President | M | Common Stock | 14625 | $59.46 | 240,063.0000 | 362,000,000 | 6.49% | 0.00% |
| March 5, 2025 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 14625 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| March 5, 2025 | Rosa David J. | President | S | Common Stock | 8140 | $557.58 | 231,923.0000 | 362,000,000 | 3.39% | 0.00% |
| Feb. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 2486 | $563.77 | 3,384.0000 | 362,000,000 | 42.35% | 0.00% |
| March 3, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 3031 | $577.30 | 353.0000 | 362,000,000 | 89.57% | 0.00% |
| Feb. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1002 | $0.00 | 1,002.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 28, 2025 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 468 | $0.00 | 1,516.0000 | 362,000,000 | 44.66% | 0.00% |
| Feb. 28, 2025 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 233 | $563.77 | 1,283.0000 | 362,000,000 | 15.37% | 0.00% |
| March 3, 2025 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 810 | $573.78 | 473.0000 | 362,000,000 | 63.13% | 0.00% |
| Feb. 28, 2025 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 468 | $0.00 | 468.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 27, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | A | Common Stock | 7518 | $0.00 | 15,537.0000 | 362,000,000 | 93.75% | 0.00% |
| Feb. 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1504 | $0.00 | 17,041.0000 | 362,000,000 | 9.68% | 0.00% |
| Feb. 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 592 | $563.77 | 16,449.0000 | 362,000,000 | 3.47% | 0.00% |
| Feb. 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 2961 | $563.77 | 13,488.0000 | 362,000,000 | 18.00% | 0.00% |
| Feb. 28, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 1504 | $0.00 | 1,503.0000 | 362,000,000 | 50.02% | 0.00% |
| Feb. 27, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | A | Common Stock | 3758 | $0.00 | 8,648.0000 | 362,000,000 | 76.85% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 752 | $0.00 | 9,400.0000 | 362,000,000 | 8.70% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 373 | $563.77 | 9,027.0000 | 362,000,000 | 3.97% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 1865 | $563.77 | 7,162.0000 | 362,000,000 | 20.66% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 94 | $290.33 | 7,256.0000 | 362,000,000 | 1.31% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 94 | $566.94 | 7,162.0000 | 362,000,000 | 1.30% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 94 | $208.90 | 7,256.0000 | 362,000,000 | 1.31% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 94 | $566.94 | 7,162.0000 | 362,000,000 | 1.30% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 94 | $0.00 | 1,128.0000 | 362,000,000 | 7.69% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 94 | $0.00 | 1,128.0000 | 362,000,000 | 7.69% | 0.00% |
| Feb. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units | 752 | $0.00 | 752.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 27, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | A | Common Stock | 3758 | $0.00 | 9,055.0000 | 362,000,000 | 70.95% | 0.00% |
| Feb. 28, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 752 | $0.00 | 9,807.0000 | 362,000,000 | 8.30% | 0.00% |
| Feb. 28, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 337 | $563.77 | 9,470.0000 | 362,000,000 | 3.44% | 0.00% |
| Feb. 28, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 1683 | $563.77 | 7,787.0000 | 362,000,000 | 17.77% | 0.00% |
| Feb. 28, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units | 752 | $0.00 | 752.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 27, 2025 | GUTHART GARY S | CEO | A | Common Stock | 12530 | $0.00 | 1,273,340.0000 | 362,000,000 | 0.99% | 0.00% |
| Feb. 28, 2025 | GUTHART GARY S | CEO | M | Common Stock | 2506 | $0.00 | 1,275,846.0000 | 362,000,000 | 0.20% | 0.00% |
| Feb. 28, 2025 | GUTHART GARY S | CEO | F | Common Stock | 1243 | $563.77 | 1,274,603.0000 | 362,000,000 | 0.10% | 0.00% |
| Feb. 28, 2025 | GUTHART GARY S | CEO | F | Common Stock | 6213 | $563.77 | 1,268,390.0000 | 362,000,000 | 0.49% | 0.00% |
| Feb. 28, 2025 | GUTHART GARY S | CEO | M | Restricted Stock Units | 2506 | $0.00 | 2,506.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 27, 2025 | Rosa David J. | President | A | Common Stock | 7518 | $0.00 | 222,153.0000 | 362,000,000 | 3.50% | 0.00% |
| Feb. 28, 2025 | Rosa David J. | President | M | Common Stock | 1504 | $0.00 | 223,657.0000 | 362,000,000 | 0.68% | 0.00% |
| Feb. 28, 2025 | Rosa David J. | President | F | Common Stock | 746 | $563.77 | 222,911.0000 | 362,000,000 | 0.33% | 0.00% |
| Feb. 28, 2025 | Rosa David J. | President | F | Common Stock | 3729 | $563.77 | 219,182.0000 | 362,000,000 | 1.67% | 0.00% |
| Feb. 28, 2025 | Rosa David J. | President | M | Restricted Stock Units | 1504 | $0.00 | 1,503.0000 | 362,000,000 | 50.02% | 0.00% |
| Feb. 27, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | A | Common Stock | 5638 | $0.00 | 15,054.0000 | 362,000,000 | 59.88% | 0.00% |
| Feb. 28, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 2798 | $563.77 | 12,824.0000 | 362,000,000 | 17.91% | 0.00% |
| Feb. 27, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Common Stock | 4385 | $0.00 | 6,281.0000 | 362,000,000 | 231.28% | 0.00% |
| Feb. 28, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 877 | $0.00 | 7,158.0000 | 362,000,000 | 13.96% | 0.00% |
| Feb. 28, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 435 | $563.77 | 6,723.0000 | 362,000,000 | 6.08% | 0.00% |
| Feb. 28, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 2175 | $563.77 | 4,548.0000 | 362,000,000 | 32.35% | 0.00% |
| March 3, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 492 | $573.78 | 4,056.0000 | 362,000,000 | 10.82% | 0.00% |
| Feb. 28, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-28-2022 | 877 | $0.00 | 877.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 27, 2025 | Curet Myriam | EVP & Chief Medical Officer | A | Common Stock | 5012 | $0.00 | 7,766.0000 | 362,000,000 | 181.99% | 0.00% |
| Feb. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1002 | $0.00 | 6,367.0000 | 362,000,000 | 18.68% | 0.00% |
| Feb. 28, 2025 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 497 | $563.77 | 5,870.0000 | 362,000,000 | 7.81% | 0.00% |
| Feb. 28, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1128 | $0.00 | 16,182.0000 | 362,000,000 | 7.49% | 0.00% |
| Feb. 28, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 560 | $563.77 | 15,622.0000 | 362,000,000 | 3.46% | 0.00% |
| Feb. 28, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-28-2022 | 1128 | $0.00 | 1,127.0000 | 362,000,000 | 50.02% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | M | Common Stock | 3816 | $0.00 | 216,527.0000 | 362,000,000 | 1.79% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | F | Common Stock | 848 | $573.74 | 212,711.0000 | 362,000,000 | 0.40% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | M | Common Stock | 1710 | $0.00 | 213,559.0000 | 362,000,000 | 0.81% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | A | Restricted Stock Units - 2-26-2025 | 9155 | $0.00 | 9,155.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | M | Restricted Stock Units - 2-26-2024 | 3816 | $0.00 | 11,447.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | M | Restricted Stock Units | 1710 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Rosa David J. | President | F | Common Stock | 1892 | $573.74 | 214,635.0000 | 362,000,000 | 0.87% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 769 | $573.74 | 4,590.0000 | 362,000,000 | 14.35% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 1717 | $0.00 | 5,359.0000 | 362,000,000 | 47.14% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 1281 | $0.00 | 5,871.0000 | 362,000,000 | 27.91% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 574 | $573.74 | 5,297.0000 | 362,000,000 | 9.78% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units | 1281 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units - 2-26-2024 | 1717 | $0.00 | 5,151.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 26, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | A | Restricted Stock Units - 2-26-2025 | 4120 | $0.00 | 4,120.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 1622 | $0.00 | 2,270.0000 | 362,000,000 | 250.31% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 805 | $573.74 | 1,465.0000 | 362,000,000 | 35.46% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 855 | $0.00 | 2,320.0000 | 362,000,000 | 58.36% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 424 | $573.74 | 1,896.0000 | 362,000,000 | 18.28% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-26-2021 | 855 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-26-2024 | 1622 | $0.00 | 4,865.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 26, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Restricted Stock Units - 2-26-2025 | 3891 | $0.00 | 3,891.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1647 | $0.00 | 9,416.0000 | 362,000,000 | 21.20% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 817 | $573.74 | 8,599.0000 | 362,000,000 | 8.68% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1622 | $0.00 | 10,221.0000 | 362,000,000 | 18.86% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 805 | $573.74 | 9,416.0000 | 362,000,000 | 7.88% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-26-2021 | 1647 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-26-2024 | 1622 | $0.00 | 4,865.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 26, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | A | Restricted Stock Units - 2-26-2025 | 2746 | $0.00 | 2,746.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1710 | $0.00 | 2,063.0000 | 362,000,000 | 484.42% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 848 | $573.74 | 1,215.0000 | 362,000,000 | 41.11% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 3053 | $0.00 | 4,268.0000 | 362,000,000 | 251.28% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 1514 | $573.74 | 2,754.0000 | 362,000,000 | 35.47% | 0.00% |
| Feb. 27, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2401 | $581.00 | 353.0000 | 362,000,000 | 87.18% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1710 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units - 2-26-2024 | 3053 | $0.00 | 6,105.0000 | 362,000,000 | 33.34% | 0.00% |
| Feb. 26, 2025 | Curet Myriam | EVP & Chief Medical Officer | A | Restricted Stock Units - 2-26-2025 | 1602 | $0.00 | 1,602.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1587 | $0.00 | 7,718.0000 | 362,000,000 | 25.88% | 0.00% |
| Feb. 26, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 625 | $573.74 | 7,093.0000 | 362,000,000 | 8.10% | 0.00% |
| Feb. 26, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1527 | $0.00 | 8,620.0000 | 362,000,000 | 21.53% | 0.00% |
| Feb. 26, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 601 | $573.74 | 8,019.0000 | 362,000,000 | 6.97% | 0.00% |
| Feb. 26, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 1587 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units - 2-26-2024 | 1527 | $0.00 | 4,578.0000 | 362,000,000 | 25.01% | 0.00% |
| Feb. 26, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 1527 | $0.00 | 4,703.0000 | 362,000,000 | 48.08% | 0.00% |
| Feb. 26, 2025 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 758 | $573.74 | 3,945.0000 | 362,000,000 | 16.12% | 0.00% |
| Feb. 26, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Restricted Stock Units - 2-26-2024 | 1527 | $0.00 | 4,578.0000 | 362,000,000 | 25.01% | 0.00% |
| Feb. 26, 2025 | LOEB GARY | EVP & Chief Legal and Complian | A | Restricted Stock Units - 2-26-2025 | 3662 | $0.00 | 3,662.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 1281 | $0.00 | 4,563.0000 | 362,000,000 | 39.03% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 635 | $573.74 | 3,928.0000 | 362,000,000 | 13.92% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 1908 | $0.00 | 5,836.0000 | 362,000,000 | 48.57% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 946 | $573.74 | 4,890.0000 | 362,000,000 | 16.21% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 54 | $347.42 | 4,944.0000 | 362,000,000 | 1.10% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 54 | $570.85 | 4,890.0000 | 362,000,000 | 1.09% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 54 | $245.60 | 4,944.0000 | 362,000,000 | 1.10% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 54 | $570.85 | 4,890.0000 | 362,000,000 | 1.09% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 54 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 54 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units | 1281 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units - 2-26-2024 | 1908 | $0.00 | 5,723.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 26, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | A | Restricted Stock Units - 2-26-2025 | 5951 | $0.00 | 5,951.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 606 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | F | Common Stock | 1503 | $573.74 | 1,258,309.0000 | 362,000,000 | 0.12% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | M | Common Stock | 4961 | $0.00 | 1,263,270.0000 | 362,000,000 | 0.39% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | F | Common Stock | 2460 | $573.74 | 1,260,810.0000 | 362,000,000 | 0.19% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | M | Restricted Stock Units | 3030 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | M | Restricted Stock Units - 2-26-2024 | 4961 | $0.00 | 14,880.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | A | Restricted Stock Units - 2-26-2025 | 1511 | $0.00 | 1,511.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units - 2-26-2024 | 611 | $0.00 | 1,831.0000 | 362,000,000 | 25.02% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | A | Restricted Stock Units - 2-26-2025 | 13732 | $0.00 | 13,732.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 606 | $0.00 | 1,041.0000 | 362,000,000 | 139.31% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 301 | $573.74 | 740.0000 | 362,000,000 | 28.91% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 611 | $0.00 | 1,351.0000 | 362,000,000 | 82.57% | 0.00% |
| Feb. 26, 2025 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 303 | $573.74 | 1,048.0000 | 362,000,000 | 22.43% | 0.00% |
| Feb. 26, 2025 | GUTHART GARY S | CEO | M | Common Stock | 3030 | $0.00 | 1,259,812.0000 | 362,000,000 | 0.24% | 0.00% |
| Feb. 12, 2025 | LOEB GARY | EVP & Chief Legal and Complian | S | Common Stock | 1300 | $583.79 | 3,176.0000 | 362,000,000 | 29.04% | 0.00% |
| Feb. 12, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 1300 | $186.55 | 4,476.0000 | 362,000,000 | 40.93% | 0.00% |
| Feb. 12, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Non-Qualified Stock Option (right to buy) | 1300 | $0.00 | 7,850.0000 | 362,000,000 | 14.21% | 0.00% |
| Feb. 12, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Non-Qualified Stock Option (right to buy) | 1300 | $0.00 | 9,150.0000 | 362,000,000 | 12.44% | 0.00% |
| Feb. 12, 2025 | LOEB GARY | EVP & Chief Legal and Complian | S | Common Stock | 1300 | $583.79 | 3,176.0000 | 362,000,000 | 29.04% | 0.00% |
| Feb. 12, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 1300 | $186.55 | 4,476.0000 | 362,000,000 | 40.93% | 0.00% |
| Feb. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 838 | $0.00 | 1,676.0000 | 362,000,000 | 33.33% | 0.00% |
| Feb. 11, 2025 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 408 | $589.75 | 353.0000 | 362,000,000 | 53.61% | 0.00% |
| Feb. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 430 | $582.98 | 761.0000 | 362,000,000 | 36.10% | 0.00% |
| Feb. 10, 2025 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 838 | $0.00 | 1,191.0000 | 362,000,000 | 237.39% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 134 | $304.67 | 3,416.0000 | 362,000,000 | 4.08% | 0.00% |
| Feb. 10, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 958 | $0.00 | 1,915.0000 | 362,000,000 | 33.34% | 0.00% |
| Feb. 10, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 388 | $582.98 | 6,131.0000 | 362,000,000 | 5.95% | 0.00% |
| Feb. 10, 2025 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 958 | $0.00 | 6,519.0000 | 362,000,000 | 17.23% | 0.00% |
| Feb. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-28-2023 | 1317 | $0.00 | 2,633.0000 | 362,000,000 | 33.34% | 0.00% |
| Feb. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 669 | $582.98 | 7,769.0000 | 362,000,000 | 7.93% | 0.00% |
| Feb. 10, 2025 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1317 | $0.00 | 8,438.0000 | 362,000,000 | 18.49% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Restricted Stock Units | 1078 | $0.00 | 2,154.0000 | 362,000,000 | 33.35% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 134 | $0.00 | 3,232.0000 | 362,000,000 | 3.98% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 135 | $0.00 | 3,232.0000 | 362,000,000 | 4.01% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 135 | $590.00 | 3,282.0000 | 362,000,000 | 3.95% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 135 | $229.39 | 3,417.0000 | 362,000,000 | 4.11% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 134 | $590.00 | 3,282.0000 | 362,000,000 | 3.92% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | F | Common Stock | 481 | $582.98 | 3,282.0000 | 362,000,000 | 12.78% | 0.00% |
| Feb. 10, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 1078 | $0.00 | 3,763.0000 | 362,000,000 | 40.15% | 0.00% |
| Feb. 10, 2025 | GUTHART GARY S | CEO | M | Restricted Stock Units | 2634 | $0.00 | 5,266.0000 | 362,000,000 | 33.34% | 0.00% |
| Feb. 10, 2025 | GUTHART GARY S | CEO | F | Common Stock | 1055 | $582.98 | 1,256,782.0000 | 362,000,000 | 0.08% | 0.00% |
| Feb. 10, 2025 | GUTHART GARY S | CEO | M | Common Stock | 2634 | $0.00 | 1,257,837.0000 | 362,000,000 | 0.21% | 0.00% |
| Feb. 10, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 838 | $0.00 | 1,078.0000 | 362,000,000 | 349.17% | 0.00% |
| Feb. 10, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 430 | $582.98 | 648.0000 | 362,000,000 | 39.89% | 0.00% |
| Feb. 10, 2025 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-28-2023 | 838 | $0.00 | 1,676.0000 | 362,000,000 | 33.33% | 0.00% |
| Feb. 10, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | F | Common Stock | 492 | $582.98 | 3,642.0000 | 362,000,000 | 11.90% | 0.00% |
| Feb. 10, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Common Stock | 1078 | $0.00 | 4,134.0000 | 362,000,000 | 35.27% | 0.00% |
| Feb. 10, 2025 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 568 | $0.00 | 1,134.0000 | 362,000,000 | 33.37% | 0.00% |
| Feb. 10, 2025 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 298 | $582.98 | 435.0000 | 362,000,000 | 40.65% | 0.00% |
| Feb. 10, 2025 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 568 | $0.00 | 733.0000 | 362,000,000 | 344.24% | 0.00% |
| Feb. 10, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Restricted Stock Units | 315 | $0.00 | 629.0000 | 362,000,000 | 33.37% | 0.00% |
| Feb. 10, 2025 | LOEB GARY | EVP & Chief Legal and Complian | F | Common Stock | 169 | $582.98 | 3,176.0000 | 362,000,000 | 5.05% | 0.00% |
| Feb. 10, 2025 | LOEB GARY | EVP & Chief Legal and Complian | M | Common Stock | 315 | $0.00 | 3,345.0000 | 362,000,000 | 10.40% | 0.00% |
| Feb. 10, 2025 | Rosa David J. | President | M | Restricted Stock Units - 2-28-2023 | 1437 | $0.00 | 2,872.0000 | 362,000,000 | 33.35% | 0.00% |
| Feb. 10, 2025 | Rosa David J. | President | F | Common Stock | 723 | $582.98 | 211,849.0000 | 362,000,000 | 0.34% | 0.00% |
| Feb. 10, 2025 | Rosa David J. | President | M | Common Stock | 1437 | $0.00 | 212,572.0000 | 362,000,000 | 0.68% | 0.00% |
| Feb. 10, 2025 | Charlton Henry L | EVP & Chief Commercial and Mkt | M | Restricted Stock Units | 1078 | $0.00 | 2,154.0000 | 362,000,000 | 33.35% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 188 | $290.33 | 8,945.0000 | 362,000,000 | 2.15% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 188 | $566.60 | 8,757.0000 | 362,000,000 | 2.10% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 105 | $347.42 | 8,862.0000 | 362,000,000 | 1.20% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 105 | $566.60 | 8,757.0000 | 362,000,000 | 1.18% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 105 | $245.60 | 8,862.0000 | 362,000,000 | 1.20% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 105 | $566.60 | 8,757.0000 | 362,000,000 | 1.18% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 135 | $304.67 | 8,892.0000 | 362,000,000 | 1.54% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 135 | $566.60 | 8,757.0000 | 362,000,000 | 1.52% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 134 | $229.39 | 8,891.0000 | 362,000,000 | 1.53% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 134 | $566.60 | 8,757.0000 | 362,000,000 | 1.51% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 94 | $208.90 | 8,851.0000 | 362,000,000 | 1.07% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 94 | $566.60 | 8,757.0000 | 362,000,000 | 1.06% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 6127 | $575.00 | 2,630.0000 | 362,000,000 | 69.97% | 0.00% |
| Jan. 29, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Common Stock | 94 | $208.90 | 2,724.0000 | 362,000,000 | 3.57% | 0.00% |
| Jan. 29, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | S | Common Stock | 94 | $571.11 | 2,630.0000 | 362,000,000 | 3.45% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 94 | $0.00 | 1,316.0000 | 362,000,000 | 6.67% | 0.00% |
| Jan. 29, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 94 | $0.00 | 1,222.0000 | 362,000,000 | 7.14% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 134 | $0.00 | 3,367.0000 | 362,000,000 | 3.83% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | 54.0000 | 362,000,000 | 66.04% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 1,222.0000 | 362,000,000 | 13.33% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 135 | $0.00 | 3,366.0000 | 362,000,000 | 3.86% | 0.00% |
| Jan. 28, 2025 | Samath Jamie | EVP & CFO & Enterprise Technol | M | Non-Qualified Stock Option (right to buy) | 105 | $0.00 | 54.0000 | 362,000,000 | 66.04% | 0.00% |
| Jan. 28, 2025 | Johnson Amal M | Director | M | Common Stock | 4635 | $90.49 | 16,910.0000 | 362,000,000 | 37.76% | 0.00% |
| Jan. 28, 2025 | Johnson Amal M | Director | S | Common Stock | 4635 | $566.60 | 12,275.0000 | 362,000,000 | 27.41% | 0.00% |
| Jan. 28, 2025 | Johnson Amal M | Director | M | Non-Qualified Stock Option (right to buy) | 4635 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Jan. 28, 2025 | Ladd Amy L | Director | S | Common Stock | 150 | $566.60 | 671.0000 | 362,000,000 | 18.27% | 0.00% |
| Dec. 10, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Common Stock | 135 | $304.67 | 8,892.0000 | 362,700,000 | 1.54% | 0.00% |
| Dec. 10, 2024 | Samath Jamie | CFO and Head of Business Techn | S | Common Stock | 135 | $540.16 | 8,757.0000 | 362,700,000 | 1.52% | 0.00% |
| Dec. 10, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Common Stock | 135 | $229.39 | 8,892.0000 | 362,700,000 | 1.54% | 0.00% |
| Dec. 10, 2024 | Samath Jamie | CFO and Head of Business Techn | S | Common Stock | 135 | $540.16 | 8,757.0000 | 362,700,000 | 1.52% | 0.00% |
| Dec. 10, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Non-Qualified Stock Option (right to buy) | 135 | $0.00 | 3,501.0000 | 362,700,000 | 3.71% | 0.00% |
| Dec. 10, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Non-Qualified Stock Option (right to buy) | 135 | $0.00 | 3,501.0000 | 362,700,000 | 3.71% | 0.00% |
| Nov. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,694.0000 | 362,700,000 | 3.41% | 0.00% |
| Nov. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $539.00 | 5,506.0000 | 362,700,000 | 3.30% | 0.00% |
| Nov. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 2,820.0000 | 362,700,000 | 6.25% | 0.00% |
| Nov. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 2,820.0000 | 362,700,000 | 6.25% | 0.00% |
| Nov. 29, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Common Stock | 94 | $290.33 | 8,851.0000 | 362,700,000 | 1.07% | 0.00% |
| Nov. 29, 2024 | Samath Jamie | CFO and Head of Business Techn | S | Common Stock | 94 | $539.00 | 8,757.0000 | 362,700,000 | 1.06% | 0.00% |
| Nov. 29, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Common Stock | 94 | $208.90 | 8,851.0000 | 362,700,000 | 1.07% | 0.00% |
| Nov. 29, 2024 | Samath Jamie | CFO and Head of Business Techn | S | Common Stock | 94 | $539.00 | 8,757.0000 | 362,700,000 | 1.06% | 0.00% |
| Nov. 29, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Non-Qualified Stock Option (right to buy) | 94 | $0.00 | 1,410.0000 | 362,700,000 | 6.25% | 0.00% |
| Nov. 29, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Non-Qualified Stock Option (right to buy) | 94 | $0.00 | 1,410.0000 | 362,700,000 | 6.25% | 0.00% |
| Nov. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 362,700,000 | 3.41% | 0.00% |
| Nov. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $539.00 | 5,506.0000 | 362,700,000 | 3.30% | 0.00% |
| Nov. 26, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Common Stock | 54 | $347.42 | 8,811.0000 | 362,700,000 | 0.62% | 0.00% |
| Nov. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 597.0000 | 362,700,000 | 24.91% | 0.00% |
| Nov. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 597.0000 | 362,700,000 | 24.91% | 0.00% |
| Nov. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $542.06 | 5,506.0000 | 362,700,000 | 3.47% | 0.00% |
| Nov. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $245.60 | 5,704.0000 | 362,700,000 | 3.60% | 0.00% |
| Nov. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $542.06 | 5,506.0000 | 362,700,000 | 3.47% | 0.00% |
| Nov. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $347.42 | 5,704.0000 | 362,700,000 | 3.60% | 0.00% |
| Nov. 26, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Non-Qualified Stock Option (right to buy) | 54 | $0.00 | 159.0000 | 362,700,000 | 25.35% | 0.00% |
| Nov. 26, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Non-Qualified Stock Option (right to buy) | 54 | $0.00 | 159.0000 | 362,700,000 | 25.35% | 0.00% |
| Nov. 26, 2024 | Samath Jamie | CFO and Head of Business Techn | S | Common Stock | 54 | $542.06 | 8,757.0000 | 362,700,000 | 0.61% | 0.00% |
| Nov. 26, 2024 | Samath Jamie | CFO and Head of Business Techn | M | Common Stock | 54 | $245.60 | 8,811.0000 | 362,700,000 | 0.62% | 0.00% |
| Nov. 26, 2024 | Samath Jamie | CFO and Head of Business Techn | S | Common Stock | 54 | $542.06 | 8,757.0000 | 362,700,000 | 0.61% | 0.00% |
| Nov. 22, 2024 | Rosa David J. | President | G | Common Stock | 915 | $0.00 | 211,080.0000 | 362,700,000 | 0.43% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2257 | $177.99 | 2,555.0000 | 362,700,000 | 757.38% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2257 | $535.96 | 298.0000 | 362,700,000 | 88.34% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 5000 | $182.83 | 5,298.0000 | 362,700,000 | 1677.85% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 5000 | $535.96 | 298.0000 | 362,700,000 | 94.38% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2199 | $229.39 | 2,497.0000 | 362,700,000 | 737.92% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2199 | $535.96 | 298.0000 | 362,700,000 | 88.07% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 4010 | $208.90 | 4,308.0000 | 362,700,000 | 1345.64% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 4010 | $535.96 | 298.0000 | 362,700,000 | 93.08% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2257 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 5000 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 4010 | $0.00 | 2,005.0000 | 362,700,000 | 66.67% | 0.00% |
| Nov. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2199 | $0.00 | 2,829.0000 | 362,700,000 | 43.74% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 3007 | $290.33 | 11,764.0000 | 362,700,000 | 34.34% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 2352 | $347.42 | 14,116.0000 | 362,700,000 | 19.99% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 2352 | $245.60 | 16,468.0000 | 362,700,000 | 16.66% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 1515 | $242.34 | 17,983.0000 | 362,700,000 | 9.20% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 1521 | $177.99 | 19,504.0000 | 362,700,000 | 8.46% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 1449 | $166.62 | 20,953.0000 | 362,700,000 | 7.43% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 1449 | $182.83 | 22,402.0000 | 362,700,000 | 6.92% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 432 | $174.26 | 22,834.0000 | 362,700,000 | 1.93% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 432 | $139.52 | 23,266.0000 | 362,700,000 | 1.89% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 2694 | $304.67 | 25,960.0000 | 362,700,000 | 11.58% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 2693 | $229.39 | 28,653.0000 | 362,700,000 | 10.37% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Common Stock | 3007 | $208.90 | 31,660.0000 | 362,700,000 | 10.49% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | S | Common Stock | 22903 | $525.00 | 8,757.0000 | 362,700,000 | 72.34% | 0.01% |
| Nov. 11, 2024 | Samath Jamie | See Remarks | M | Common Stock | 134 | $304.67 | 8,891.0000 | 362,700,000 | 1.53% | 0.00% |
| Nov. 11, 2024 | Samath Jamie | See Remarks | M | Common Stock | 135 | $229.39 | 9,026.0000 | 362,700,000 | 1.52% | 0.00% |
| Nov. 11, 2024 | Samath Jamie | See Remarks | S | Common Stock | 269 | $539.89 | 8,757.0000 | 362,700,000 | 2.98% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 3007 | $0.00 | 1,504.0000 | 362,700,000 | 66.66% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 2352 | $0.00 | 213.0000 | 362,700,000 | 91.70% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 2352 | $0.00 | 213.0000 | 362,700,000 | 91.70% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 1515 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 1521 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 1449 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 1449 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 432 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 432 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 2694 | $0.00 | 3,770.0000 | 362,700,000 | 41.68% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 2693 | $0.00 | 3,771.0000 | 362,700,000 | 41.66% | 0.00% |
| Nov. 8, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 3007 | $0.00 | 1,504.0000 | 362,700,000 | 66.66% | 0.00% |
| Nov. 11, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 135 | $0.00 | 3,636.0000 | 362,700,000 | 3.58% | 0.00% |
| Nov. 11, 2024 | Samath Jamie | See Remarks | M | Non-Qualified Stock Option (right to buy) | 134 | $0.00 | 3,636.0000 | 362,700,000 | 3.55% | 0.00% |
| Nov. 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $304.67 | 5,626.0000 | 362,700,000 | 2.18% | 0.00% |
| Nov. 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $539.89 | 5,506.0000 | 362,700,000 | 2.13% | 0.00% |
| Nov. 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $229.39 | 5,625.0000 | 362,700,000 | 2.16% | 0.00% |
| Nov. 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $539.89 | 5,506.0000 | 362,700,000 | 2.12% | 0.00% |
| Nov. 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 3,233.0000 | 362,700,000 | 3.55% | 0.00% |
| Nov. 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,232.0000 | 362,700,000 | 3.58% | 0.00% |
| Nov. 5, 2024 | Rosa David J. | President | G | Common Stock | 1980 | $0.00 | 213,975.0000 | 362,700,000 | 0.92% | 0.00% |
| Nov. 5, 2024 | Rosa David J. | President | G | Common Stock | 1980 | $0.00 | 211,995.0000 | 362,700,000 | 0.93% | 0.00% |
| Oct. 30, 2024 | GUTHART GARY S | CEO | M | Common Stock | 25200 | $59.23 | 1,273,354.0000 | 362,700,000 | 2.02% | 0.01% |
| Oct. 30, 2024 | GUTHART GARY S | CEO | S | Common Stock | 18151 | $511.63 | 1,255,203.0000 | 362,700,000 | 1.43% | 0.01% |
| Oct. 30, 2024 | GUTHART GARY S | CEO | S | Common Stock | 3720 | $510.52 | 1,255,203.0000 | 362,700,000 | 0.30% | 0.00% |
| Oct. 30, 2024 | GUTHART GARY S | CEO | S | Common Stock | 3720 | $510.75 | 1,255,203.0000 | 362,700,000 | 0.30% | 0.00% |
| Oct. 30, 2024 | GUTHART GARY S | CEO | M | Non-Qualified Stock Option (right to buy) | 25200 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.01% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 362,700,000 | 3.41% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $514.00 | 5,506.0000 | 362,700,000 | 3.30% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $347.42 | 5,704.0000 | 362,700,000 | 3.60% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $514.00 | 5,506.0000 | 362,700,000 | 3.47% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $245.60 | 5,704.0000 | 362,700,000 | 3.60% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $514.00 | 5,506.0000 | 362,700,000 | 3.47% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $304.67 | 5,626.0000 | 362,700,000 | 2.18% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $514.00 | 5,506.0000 | 362,700,000 | 2.13% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $229.39 | 5,626.0000 | 362,700,000 | 2.18% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $514.00 | 5,506.0000 | 362,700,000 | 2.13% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,694.0000 | 362,700,000 | 3.41% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $514.00 | 5,506.0000 | 362,700,000 | 3.30% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 362,700,000 | 3.41% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $513.66 | 5,506.0000 | 362,700,000 | 3.30% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $347.42 | 5,704.0000 | 362,700,000 | 3.60% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $513.66 | 5,506.0000 | 362,700,000 | 3.47% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $245.60 | 5,704.0000 | 362,700,000 | 3.60% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $513.66 | 5,506.0000 | 362,700,000 | 3.47% | 0.00% |
| Oct. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,694.0000 | 362,700,000 | 3.41% | 0.00% |
| Oct. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $506.52 | 5,506.0000 | 362,700,000 | 3.30% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,196.0000 | 362,700,000 | 5.56% | 0.00% |
| Oct. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,008.0000 | 362,700,000 | 5.88% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,352.0000 | 362,700,000 | 3.46% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 993.0000 | 362,700,000 | 16.62% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 795.0000 | 362,700,000 | 19.94% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,196.0000 | 362,700,000 | 5.56% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,008.0000 | 362,700,000 | 5.88% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,352.0000 | 362,700,000 | 3.46% | 0.00% |
| Oct. 25, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 993.0000 | 362,700,000 | 16.62% | 0.00% |
| Oct. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 795.0000 | 362,700,000 | 19.94% | 0.00% |
| Oct. 25, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $514.00 | 207.0000 | 362,700,000 | 9.61% | 0.00% |
| Oct. 28, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $513.66 | 185.0000 | 362,700,000 | 10.63% | 0.00% |
| Oct. 22, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 2106 | $77.00 | 2,401.0000 | 362,700,000 | 713.90% | 0.00% |
| Oct. 22, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 2106 | $515.00 | 295.0000 | 362,700,000 | 87.71% | 0.00% |
| Oct. 22, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $515.00 | 273.0000 | 362,700,000 | 7.46% | 0.00% |
| Oct. 23, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $513.89 | 251.0000 | 362,700,000 | 8.06% | 0.00% |
| Oct. 24, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 22 | $510.79 | 229.0000 | 362,700,000 | 8.76% | 0.00% |
| Oct. 22, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Non-Qualified Stock Option (right to buy) | 2106 | $0.00 | 0.0000 | 362,700,000 | 100.00% | 0.00% |
| Oct. 22, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 2553 | $515.00 | 7,066.0000 | 362,700,000 | 26.54% | 0.00% |
| Oct. 10, 2024 | LOEB GARY | General Counsel | F | Common Stock | 1178 | $490.38 | 3,030.0000 | 362,700,000 | 27.99% | 0.00% |
| Oct. 10, 2024 | LOEB GARY | General Counsel | M | Common Stock | 2613 | $0.00 | 4,208.0000 | 362,700,000 | 163.82% | 0.00% |
| Oct. 10, 2024 | LOEB GARY | General Counsel | M | Restricted Stock Units | 2613 | $0.00 | 5,224.0000 | 362,700,000 | 33.34% | 0.00% |
| Sept. 13, 2024 | Ladd Amy L | Director | S | Common Stock | 450 | $490.28 | 821.0000 | 357,400,000 | 35.41% | 0.00% |
| Sept. 12, 2024 | Brosius Mark | See Remarks | M | Common Stock | 2115 | $59.46 | 2,410.0000 | 357,400,000 | 716.95% | 0.00% |
| Sept. 12, 2024 | Brosius Mark | See Remarks | S | Common Stock | 2115 | $491.91 | 295.0000 | 357,400,000 | 87.76% | 0.00% |
| Sept. 12, 2024 | Brosius Mark | See Remarks | M | Non-Qualified Stock Option | 2115 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Sept. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 3,472.0000 | 357,400,000 | 3.31% | 0.00% |
| Sept. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $477.50 | 5,506.0000 | 357,400,000 | 2.12% | 0.00% |
| Sept. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $229.39 | 5,625.0000 | 357,400,000 | 2.16% | 0.00% |
| Sept. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $477.50 | 5,506.0000 | 357,400,000 | 2.12% | 0.00% |
| Sept. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $304.67 | 5,625.0000 | 357,400,000 | 2.16% | 0.00% |
| Sept. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 3,472.0000 | 357,400,000 | 3.31% | 0.00% |
| Sept. 9, 2024 | LOEB GARY | General Counsel | S | Common Stock | 300 | $475.00 | 1,595.0000 | 357,400,000 | 15.83% | 0.00% |
| Aug. 31, 2024 | MOHR MARSHALL | Executive VP Global Business S | A | Common Stock | 3348 | $0.00 | 153,203.0000 | 357,400,000 | 2.23% | 0.00% |
| Aug. 31, 2024 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 1698 | $492.63 | 151,505.0000 | 357,400,000 | 1.11% | 0.00% |
| Aug. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,384.0000 | 357,400,000 | 5.26% | 0.00% |
| Aug. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $482.21 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| Aug. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| Aug. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $482.93 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| Aug. 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| Aug. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,384.0000 | 357,400,000 | 5.26% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 5203 | $109.49 | 28,689.0000 | 357,400,000 | 22.15% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 3750 | $486.81 | 23,486.0000 | 357,400,000 | 13.77% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 3750 | $139.52 | 27,236.0000 | 357,400,000 | 15.97% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 1336 | $486.85 | 23,486.0000 | 357,400,000 | 5.38% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 1336 | $174.26 | 24,822.0000 | 357,400,000 | 5.69% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 2414 | $486.81 | 23,486.0000 | 357,400,000 | 9.32% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 2414 | $174.26 | 25,900.0000 | 357,400,000 | 10.28% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 2625 | $486.85 | 23,486.0000 | 357,400,000 | 10.05% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 2625 | $182.83 | 26,111.0000 | 357,400,000 | 11.18% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 2625 | $486.85 | 23,486.0000 | 357,400,000 | 10.05% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 2625 | $166.62 | 26,111.0000 | 357,400,000 | 11.18% | 0.00% |
| Aug. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 1,191.0000 | 357,400,000 | 14.25% | 0.00% |
| Aug. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 1,191.0000 | 357,400,000 | 14.25% | 0.00% |
| Aug. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $245.60 | 5,704.0000 | 357,400,000 | 3.60% | 0.00% |
| Aug. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $486.88 | 5,506.0000 | 357,400,000 | 3.47% | 0.00% |
| Aug. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $347.42 | 5,704.0000 | 357,400,000 | 3.60% | 0.00% |
| Aug. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $486.88 | 5,506.0000 | 357,400,000 | 3.47% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 2625 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 1336 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 2414 | $0.00 | 1,336.0000 | 357,400,000 | 64.37% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 2625 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 3750 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 422 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 5203 | $0.00 | 422.0000 | 357,400,000 | 92.50% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 468 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 456 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Non-Qualified Stock Option (right to buy) | 459 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 6829 | $486.85 | 3,001.0000 | 357,400,000 | 69.47% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 6828 | $486.86 | 9,830.0000 | 357,400,000 | 40.99% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 6828 | $486.82 | 16,658.0000 | 357,400,000 | 29.07% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 459 | $486.84 | 23,486.0000 | 357,400,000 | 1.92% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 459 | $59.46 | 23,945.0000 | 357,400,000 | 1.95% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 456 | $486.84 | 23,486.0000 | 357,400,000 | 1.90% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 456 | $77.00 | 23,942.0000 | 357,400,000 | 1.94% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 5203 | $486.84 | 23,486.0000 | 357,400,000 | 18.14% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 422 | $109.49 | 23,908.0000 | 357,400,000 | 1.80% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 422 | $486.81 | 23,486.0000 | 357,400,000 | 1.77% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 468 | $79.64 | 23,954.0000 | 357,400,000 | 1.99% | 0.00% |
| Aug. 23, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | S | Common Stock | 468 | $486.84 | 23,486.0000 | 357,400,000 | 1.95% | 0.00% |
| Aug. 12, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $304.67 | 5,626.0000 | 357,400,000 | 2.18% | 0.00% |
| Aug. 12, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,591.0000 | 357,400,000 | 3.23% | 0.00% |
| Aug. 12, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,591.0000 | 357,400,000 | 3.23% | 0.00% |
| Aug. 12, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $464.76 | 5,506.0000 | 357,400,000 | 2.13% | 0.00% |
| Aug. 12, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $229.39 | 5,626.0000 | 357,400,000 | 2.18% | 0.00% |
| Aug. 12, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $464.76 | 5,506.0000 | 357,400,000 | 2.13% | 0.00% |
| Aug. 1, 2024 | Johnson Amal M | Not found | S | Common Stock | 2943 | $443.30 | 12,275.0000 | 357,400,000 | 19.34% | 0.00% |
| Aug. 1, 2024 | Johnson Amal M | Not found | M | Non-Qualified Stock Option (right to buy) | 2943 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Aug. 1, 2024 | Johnson Amal M | Not found | M | Common Stock | 2943 | $71.32 | 15,218.0000 | 357,400,000 | 23.98% | 0.00% |
| July 30, 2024 | GUTHART GARY S | CEO | M | Common Stock | 25200 | $57.11 | 1,278,982.0000 | 357,400,000 | 2.01% | 0.01% |
| July 30, 2024 | GUTHART GARY S | CEO | S | Common Stock | 3720 | $445.12 | 1,255,594.0000 | 357,400,000 | 0.30% | 0.00% |
| July 30, 2024 | GUTHART GARY S | CEO | M | Non-Qualified Stock Option (right to buy) | 25200 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| July 30, 2024 | GUTHART GARY S | CEO | G | Common Stock | 12500 | $0.00 | 1,255,594.0000 | 357,400,000 | 0.99% | 0.00% |
| July 30, 2024 | GUTHART GARY S | CEO | S | Common Stock | 23388 | $443.07 | 1,255,594.0000 | 357,400,000 | 1.83% | 0.01% |
| July 30, 2024 | GUTHART GARY S | CEO | S | Common Stock | 3720 | $445.07 | 1,255,594.0000 | 357,400,000 | 0.30% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 399 | $438.60 | 5,506.0000 | 357,400,000 | 6.76% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 399 | $245.60 | 5,905.0000 | 357,400,000 | 7.25% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 399 | $438.60 | 5,506.0000 | 357,400,000 | 6.76% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $304.67 | 5,626.0000 | 357,400,000 | 2.18% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 399 | $0.00 | 1,389.0000 | 357,400,000 | 22.32% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $229.39 | 5,626.0000 | 357,400,000 | 2.18% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $438.60 | 5,506.0000 | 357,400,000 | 2.13% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 187 | $0.00 | 3,760.0000 | 357,400,000 | 4.74% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 187 | $208.90 | 5,693.0000 | 357,400,000 | 3.40% | 0.00% |
| July 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,572.0000 | 357,400,000 | 5.00% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 187 | $438.60 | 5,506.0000 | 357,400,000 | 3.28% | 0.00% |
| July 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| July 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $446.60 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 399 | $0.00 | 1,389.0000 | 357,400,000 | 22.32% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,760.0000 | 357,400,000 | 4.76% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,711.0000 | 357,400,000 | 3.13% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $438.60 | 5,506.0000 | 357,400,000 | 2.13% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,711.0000 | 357,400,000 | 3.13% | 0.00% |
| July 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,572.0000 | 357,400,000 | 5.00% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $438.60 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| July 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 399 | $347.42 | 5,905.0000 | 357,400,000 | 7.25% | 0.00% |
| July 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| July 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $446.60 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| July 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2818 | $0.00 | 2,257.0000 | 357,400,000 | 55.53% | 0.00% |
| July 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2818 | $458.13 | 298.0000 | 357,400,000 | 90.44% | 0.00% |
| July 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2818 | $177.99 | 3,116.0000 | 357,400,000 | 945.64% | 0.00% |
| July 23, 2024 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 1400 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| July 23, 2024 | BARRATT CRAIG H | Director | S | Common Stock | 1400 | $458.13 | 26,155.0000 | 357,400,000 | 5.08% | 0.00% |
| July 23, 2024 | BARRATT CRAIG H | Director | M | Common Stock | 1400 | $56.97 | 27,555.0000 | 357,400,000 | 5.35% | 0.00% |
| June 12, 2024 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 1400 | $0.00 | 1,400.0000 | 357,400,000 | 50.00% | 0.00% |
| June 12, 2024 | BARRATT CRAIG H | Director | S | Common Stock | 1400 | $421.06 | 26,155.0000 | 357,400,000 | 5.08% | 0.00% |
| June 12, 2024 | BARRATT CRAIG H | Director | M | Common Stock | 1400 | $56.97 | 27,555.0000 | 357,400,000 | 5.35% | 0.00% |
| June 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 3,831.0000 | 357,400,000 | 3.01% | 0.00% |
| June 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,831.0000 | 357,400,000 | 3.04% | 0.00% |
| June 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $416.60 | 5,506.0000 | 357,400,000 | 2.13% | 0.00% |
| June 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $229.39 | 5,626.0000 | 357,400,000 | 2.18% | 0.00% |
| June 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $416.60 | 5,506.0000 | 357,400,000 | 2.12% | 0.00% |
| June 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $304.67 | 5,625.0000 | 357,400,000 | 2.16% | 0.00% |
| June 10, 2024 | Rosa David J. | President | M | Restricted Stock Units - 6-12-23 | 1359 | $0.00 | 4,074.0000 | 357,400,000 | 25.01% | 0.00% |
| June 10, 2024 | Rosa David J. | President | F | Common Stock | 689 | $417.61 | 215,955.0000 | 357,400,000 | 0.32% | 0.00% |
| June 10, 2024 | Rosa David J. | President | M | Common Stock | 1359 | $0.00 | 216,644.0000 | 357,400,000 | 0.63% | 0.00% |
| June 5, 2024 | BARRATT CRAIG H | Director | S | Common Stock | 1400 | $411.00 | 26,155.0000 | 357,400,000 | 5.08% | 0.00% |
| June 5, 2024 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 1400 | $0.00 | 2,800.0000 | 357,400,000 | 33.33% | 0.00% |
| June 5, 2024 | BARRATT CRAIG H | Director | M | Common Stock | 1400 | $56.97 | 27,555.0000 | 357,400,000 | 5.35% | 0.00% |
| June 3, 2024 | BARRATT CRAIG H | Director | M | Common Stock | 1400 | $56.97 | 27,555.0000 | 357,400,000 | 5.35% | 0.00% |
| June 3, 2024 | BARRATT CRAIG H | Director | S | Common Stock | 1400 | $402.89 | 26,155.0000 | 357,400,000 | 5.08% | 0.00% |
| June 3, 2024 | BARRATT CRAIG H | Director | M | Common Stock | 1096 | $56.97 | 27,251.0000 | 357,400,000 | 4.19% | 0.00% |
| June 3, 2024 | BARRATT CRAIG H | Director | S | Common Stock | 1096 | $402.89 | 26,155.0000 | 357,400,000 | 4.02% | 0.00% |
| June 3, 2024 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 1400 | $0.00 | 5,296.0000 | 357,400,000 | 20.91% | 0.00% |
| June 3, 2024 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 1096 | $0.00 | 4,200.0000 | 357,400,000 | 20.69% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $404.41 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $347.42 | 5,704.0000 | 357,400,000 | 3.60% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $404.41 | 5,506.0000 | 357,400,000 | 3.47% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 198 | $245.60 | 5,704.0000 | 357,400,000 | 3.60% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 198 | $404.41 | 5,506.0000 | 357,400,000 | 3.47% | 0.00% |
| May 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,694.0000 | 357,400,000 | 3.41% | 0.00% |
| May 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $396.59 | 5,506.0000 | 357,400,000 | 3.30% | 0.00% |
| May 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,947.0000 | 357,400,000 | 4.55% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 1,788.0000 | 357,400,000 | 9.97% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 3,948.0000 | 357,400,000 | 4.55% | 0.00% |
| May 28, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 198 | $0.00 | 1,788.0000 | 357,400,000 | 9.97% | 0.00% |
| May 16, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 175 | $398.28 | 358.0000 | 357,400,000 | 32.83% | 0.00% |
| May 17, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 63 | $396.19 | 295.0000 | 357,400,000 | 17.60% | 0.00% |
| May 16, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | S | Common Stock | 2553 | $400.00 | 9,619.0000 | 357,400,000 | 20.97% | 0.00% |
| May 17, 2024 | Rosa David J. | President | G | Common Stock | 2507 | $0.00 | 215,285.0000 | 357,400,000 | 1.15% | 0.00% |
| May 13, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 175 | $389.16 | 883.0000 | 357,400,000 | 16.54% | 0.00% |
| May 14, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 175 | $380.85 | 708.0000 | 357,400,000 | 19.82% | 0.00% |
| May 15, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 175 | $387.22 | 533.0000 | 357,400,000 | 24.72% | 0.00% |
| May 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $304.67 | 5,627.0000 | 357,400,000 | 2.18% | 0.00% |
| May 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $385.55 | 5,507.0000 | 357,400,000 | 2.13% | 0.00% |
| May 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $229.39 | 5,626.0000 | 357,400,000 | 2.16% | 0.00% |
| May 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $385.55 | 5,507.0000 | 357,400,000 | 2.12% | 0.00% |
| May 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 360 | $0.00 | 5,867.0000 | 357,400,000 | 6.54% | 0.00% |
| May 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 167 | $386.70 | 5,700.0000 | 357,400,000 | 2.85% | 0.00% |
| May 13, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 90 | $179.70 | 5,790.0000 | 357,400,000 | 1.58% | 0.00% |
| May 13, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 90 | $389.16 | 5,700.0000 | 357,400,000 | 1.55% | 0.00% |
| May 13, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 194 | $389.16 | 5,506.0000 | 357,400,000 | 3.40% | 0.00% |
| May 13, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 90 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| May 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 3,951.0000 | 357,400,000 | 2.92% | 0.00% |
| May 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 3,950.0000 | 357,400,000 | 2.95% | 0.00% |
| May 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 360 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| May 3, 2024 | RUBASH MARK J | Director | M | Common Stock | 1709 | $295.92 | 17,760.0000 | 357,400,000 | 10.65% | 0.00% |
| May 3, 2024 | RUBASH MARK J | Director | S | Common Stock | 1709 | $380.00 | 16,051.0000 | 357,400,000 | 9.62% | 0.00% |
| May 3, 2024 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,695.0000 | 357,400,000 | 3.41% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $368.10 | 5,507.0000 | 357,400,000 | 3.30% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 396 | $347.42 | 5,903.0000 | 357,400,000 | 7.19% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 396 | $375.00 | 5,507.0000 | 357,400,000 | 6.71% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 396 | $245.60 | 5,903.0000 | 357,400,000 | 7.19% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 396 | $368.10 | 5,507.0000 | 357,400,000 | 6.71% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 90 | $179.70 | 5,597.0000 | 357,400,000 | 1.63% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 90 | $368.10 | 5,507.0000 | 357,400,000 | 1.61% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $304.67 | 5,627.0000 | 357,400,000 | 2.18% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $368.10 | 5,507.0000 | 357,400,000 | 2.13% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $229.39 | 5,627.0000 | 357,400,000 | 2.18% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $368.10 | 5,507.0000 | 357,400,000 | 2.13% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,695.0000 | 357,400,000 | 3.41% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $368.10 | 5,507.0000 | 357,400,000 | 3.30% | 0.00% |
| April 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $290.33 | 5,695.0000 | 357,400,000 | 3.41% | 0.00% |
| April 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $375.39 | 5,507.0000 | 357,400,000 | 3.30% | 0.00% |
| April 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 188 | $208.90 | 5,695.0000 | 357,400,000 | 3.41% | 0.00% |
| April 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 188 | $375.39 | 5,507.0000 | 357,400,000 | 3.30% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 90 | $0.00 | 90.0000 | 357,400,000 | 50.00% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 4,323.0000 | 357,400,000 | 4.17% | 0.00% |
| April 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 4,135.0000 | 357,400,000 | 4.35% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 4,070.0000 | 357,400,000 | 2.86% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 396 | $0.00 | 1,986.0000 | 357,400,000 | 16.62% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 4,324.0000 | 357,400,000 | 4.17% | 0.00% |
| April 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 188 | $0.00 | 4,136.0000 | 357,400,000 | 4.35% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 4,070.0000 | 357,400,000 | 2.86% | 0.00% |
| April 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 396 | $0.00 | 1,986.0000 | 357,400,000 | 16.62% | 0.00% |
| April 25, 2024 | RUBASH MARK J | Director | M | Common Stock | 569 | $0.00 | 16,051.0000 | 357,400,000 | 3.68% | 0.00% |
| April 25, 2024 | RUBASH MARK J | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | RUBASH MARK J | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | CHEW LEWIS | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | NACHTSHEIM JAMI K | Director | M | Common Stock | 569 | $0.00 | 5,632.0000 | 357,400,000 | 11.24% | 0.00% |
| April 25, 2024 | NACHTSHEIM JAMI K | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | NACHTSHEIM JAMI K | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | Kolli Sreelakshmi | Director | M | Common Stock | 240 | $0.00 | 240.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | Kolli Sreelakshmi | Director | M | Restricted Stock Units | 240 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Kolli Sreelakshmi | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | Leonard Keith R | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | KANIA DON R | Director | M | Common Stock | 569 | $0.00 | 3,838.0000 | 357,400,000 | 17.41% | 0.00% |
| April 25, 2024 | KANIA DON R | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Johnson Amal M | Director | M | Common Stock | 569 | $0.00 | 12,275.0000 | 357,400,000 | 4.86% | 0.00% |
| April 25, 2024 | Johnson Amal M | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Johnson Amal M | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | Ladd Amy L | Director | M | Common Stock | 569 | $0.00 | 1,271.0000 | 357,400,000 | 81.05% | 0.00% |
| April 25, 2024 | Ladd Amy L | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Ladd Amy L | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | Leonard Keith R | Director | M | Common Stock | 569 | $0.00 | 1,606.0000 | 357,400,000 | 54.87% | 0.00% |
| April 25, 2024 | Leonard Keith R | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Beery Joseph C | Director | M | Common Stock | 569 | $0.00 | 2,371.0000 | 357,400,000 | 31.58% | 0.00% |
| April 25, 2024 | Beery Joseph C | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Beery Joseph C | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | BARRATT CRAIG H | Director | M | Common Stock | 804 | $0.00 | 26,155.0000 | 357,400,000 | 3.17% | 0.00% |
| April 25, 2024 | BARRATT CRAIG H | Director | M | Restricted Stock Units | 804 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | BARRATT CRAIG H | Director | A | Restricted Stock Units | 1043 | $0.00 | 1,043.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | Reed Monica P | Director | M | Common Stock | 569 | $0.00 | 1,606.0000 | 357,400,000 | 54.87% | 0.00% |
| April 25, 2024 | Reed Monica P | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 25, 2024 | Reed Monica P | Director | A | Restricted Stock Units | 739 | $0.00 | 739.0000 | 357,400,000 | 9999.99% | 0.00% |
| April 25, 2024 | LEVY ALAN J | Director | M | Common Stock | 569 | $0.00 | 25,888.0000 | 357,400,000 | 2.25% | 0.00% |
| April 25, 2024 | LEVY ALAN J | Director | M | Restricted Stock Units | 569 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| April 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2500 | $182.83 | 2,798.0000 | 357,400,000 | 838.93% | 0.00% |
| April 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2500 | $370.66 | 298.0000 | 357,400,000 | 89.35% | 0.00% |
| April 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2818 | $0.00 | 5,075.0000 | 357,400,000 | 35.70% | 0.00% |
| April 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2500 | $0.00 | 5,000.0000 | 357,400,000 | 33.33% | 0.00% |
| April 23, 2024 | LEVY ALAN J | Director | M | Common Stock | 2000 | $154.24 | 27,319.0000 | 357,400,000 | 7.90% | 0.00% |
| April 23, 2024 | LEVY ALAN J | Director | S | Common Stock | 2000 | $370.70 | 25,319.0000 | 357,400,000 | 7.32% | 0.00% |
| April 23, 2024 | LEVY ALAN J | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 916.0000 | 357,400,000 | 68.59% | 0.00% |
| April 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2818 | $177.99 | 3,116.0000 | 357,400,000 | 945.64% | 0.00% |
| April 23, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2818 | $370.66 | 298.0000 | 357,400,000 | 90.44% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 612 | $397.07 | 110.0000 | 357,400,000 | 84.76% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | M | Non-Qualified Stock Option (right to buy) | 612 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | M | Non-Qualified Stock Option (right to buy) | 612 | $0.00 | 612.0000 | 357,400,000 | 50.00% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 612 | $397.07 | 110.0000 | 357,400,000 | 84.76% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 3817 | $397.07 | 110.0000 | 357,400,000 | 97.20% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 612 | $59.23 | 722.0000 | 357,400,000 | 556.36% | 0.00% |
| March 15, 2024 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 612 | $59.23 | 722.0000 | 357,400,000 | 556.36% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 90 | $0.00 | 180.0000 | 357,400,000 | 33.33% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 1436 | $0.00 | 4,310.0000 | 357,400,000 | 24.99% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 120 | $0.00 | 4,190.0000 | 357,400,000 | 2.78% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 453 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 993 | $0.00 | 2,382.0000 | 357,400,000 | 29.42% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 1504 | $0.00 | 4,512.0000 | 357,400,000 | 25.00% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 1437 | $0.00 | 4,309.0000 | 357,400,000 | 25.01% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 119 | $0.00 | 4,190.0000 | 357,400,000 | 2.76% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 7149 | $0.00 | 2,382.0000 | 357,400,000 | 75.01% | 0.00% |
| March 8, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 196 | $392.02 | 1,254.0000 | 357,400,000 | 13.52% | 0.00% |
| March 11, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 196 | $390.16 | 1,058.0000 | 357,400,000 | 15.63% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1504 | $290.33 | 12,579.0000 | 357,400,000 | 13.58% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 1504 | $393.81 | 11,075.0000 | 357,400,000 | 11.96% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 7149 | $347.42 | 18,224.0000 | 357,400,000 | 64.55% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 7149 | $393.78 | 11,075.0000 | 357,400,000 | 39.23% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 993 | $245.60 | 12,068.0000 | 357,400,000 | 8.97% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 993 | $393.80 | 11,075.0000 | 357,400,000 | 8.23% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 453 | $242.34 | 11,528.0000 | 357,400,000 | 4.09% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 453 | $393.80 | 11,075.0000 | 357,400,000 | 3.93% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 363 | $179.70 | 11,438.0000 | 357,400,000 | 3.28% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 363 | $393.80 | 11,075.0000 | 357,400,000 | 3.17% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 453 | $177.99 | 11,528.0000 | 357,400,000 | 4.09% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 453 | $393.80 | 11,075.0000 | 357,400,000 | 3.93% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1437 | $304.67 | 12,512.0000 | 357,400,000 | 12.98% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 1437 | $393.80 | 11,075.0000 | 357,400,000 | 11.48% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1436 | $229.39 | 12,511.0000 | 357,400,000 | 12.97% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 1436 | $393.82 | 11,075.0000 | 357,400,000 | 11.48% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 940 | $208.90 | 12,015.0000 | 357,400,000 | 8.49% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 940 | $393.82 | 11,075.0000 | 357,400,000 | 7.82% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 2819 | $393.79 | 8,256.0000 | 357,400,000 | 25.45% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 2749 | $393.83 | 5,507.0000 | 357,400,000 | 33.30% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 90 | $179.70 | 5,597.0000 | 357,400,000 | 1.63% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 90 | $390.16 | 5,507.0000 | 357,400,000 | 1.61% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 119 | $304.67 | 5,626.0000 | 357,400,000 | 2.16% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 119 | $390.16 | 5,507.0000 | 357,400,000 | 2.12% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 120 | $229.39 | 5,627.0000 | 357,400,000 | 2.18% | 0.00% |
| March 11, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 120 | $390.16 | 5,507.0000 | 357,400,000 | 2.13% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 453 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 363 | $0.00 | 270.0000 | 357,400,000 | 57.35% | 0.00% |
| March 8, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 940 | $0.00 | 4,511.0000 | 357,400,000 | 17.24% | 0.00% |
| March 6, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 196 | $386.76 | 1,646.0000 | 357,400,000 | 10.64% | 0.00% |
| March 7, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 196 | $393.30 | 1,450.0000 | 357,400,000 | 11.91% | 0.00% |
| March 5, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 196 | $400.00 | 1,842.0000 | 357,400,000 | 9.62% | 0.00% |
| Feb. 29, 2024 | GUTHART GARY S | CEO | M | Restricted Stock Units | 2506 | $0.00 | 5,012.0000 | 357,400,000 | 33.33% | 0.00% |
| Feb. 29, 2024 | GUTHART GARY S | CEO | F | Common Stock | 1959 | $386.59 | 1,272,487.0000 | 357,400,000 | 0.15% | 0.00% |
| Feb. 29, 2024 | GUTHART GARY S | CEO | M | Common Stock | 3864 | $0.00 | 1,274,446.0000 | 357,400,000 | 0.30% | 0.00% |
| Feb. 29, 2024 | GUTHART GARY S | CEO | M | Common Stock | 2506 | $0.00 | 1,274,993.0000 | 357,400,000 | 0.20% | 0.00% |
| March 1, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1605 | $383.48 | 298.0000 | 357,400,000 | 84.34% | 0.00% |
| Feb. 29, 2024 | GUTHART GARY S | CEO | F | Common Stock | 1271 | $386.59 | 1,273,722.0000 | 357,400,000 | 0.10% | 0.00% |
| Feb. 29, 2024 | GUTHART GARY S | CEO | M | Restricted Stock Units | 3864 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 856 | $386.59 | 12,172.0000 | 357,400,000 | 6.57% | 0.00% |
| Feb. 29, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1689 | $0.00 | 13,028.0000 | 357,400,000 | 14.90% | 0.00% |
| Feb. 29, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 572 | $386.59 | 11,339.0000 | 357,400,000 | 4.80% | 0.00% |
| Feb. 29, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1128 | $0.00 | 11,911.0000 | 357,400,000 | 10.46% | 0.00% |
| Feb. 29, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-28-2022 | 877 | $0.00 | 1,754.0000 | 357,400,000 | 33.33% | 0.00% |
| Feb. 29, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-28-2020 | 966 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 445 | $386.59 | 2,038.0000 | 357,400,000 | 17.92% | 0.00% |
| Feb. 29, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 490 | $386.59 | 1,606.0000 | 357,400,000 | 23.38% | 0.00% |
| Feb. 29, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 966 | $0.00 | 2,096.0000 | 357,400,000 | 85.49% | 0.00% |
| Feb. 29, 2024 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 752 | $0.00 | 1,504.0000 | 357,400,000 | 33.33% | 0.00% |
| Feb. 29, 2024 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 1254 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Samath Jamie | Chief Financial Officer | F | Common Stock | 382 | $386.59 | 8,757.0000 | 357,400,000 | 4.18% | 0.00% |
| Feb. 29, 2024 | Samath Jamie | Chief Financial Officer | M | Common Stock | 752 | $0.00 | 9,139.0000 | 357,400,000 | 8.97% | 0.00% |
| Feb. 29, 2024 | Samath Jamie | Chief Financial Officer | F | Common Stock | 605 | $386.59 | 8,387.0000 | 357,400,000 | 6.73% | 0.00% |
| Feb. 29, 2024 | Samath Jamie | Chief Financial Officer | M | Common Stock | 1254 | $0.00 | 8,992.0000 | 357,400,000 | 16.21% | 0.00% |
| Feb. 29, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 877 | $0.00 | 2,483.0000 | 357,400,000 | 54.61% | 0.00% |
| Feb. 29, 2024 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 849 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 468 | $0.00 | 936.0000 | 357,400,000 | 33.33% | 0.00% |
| Feb. 29, 2024 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 167 | $386.59 | 3,927.0000 | 357,400,000 | 4.08% | 0.00% |
| Feb. 29, 2024 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 468 | $0.00 | 4,094.0000 | 357,400,000 | 12.91% | 0.00% |
| Feb. 29, 2024 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 303 | $386.59 | 3,626.0000 | 357,400,000 | 7.71% | 0.00% |
| Feb. 29, 2024 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 849 | $0.00 | 3,929.0000 | 357,400,000 | 27.56% | 0.00% |
| Feb. 29, 2024 | Rosa David J. | President | M | Restricted Stock Units | 1504 | $0.00 | 3,007.0000 | 357,400,000 | 33.34% | 0.00% |
| Feb. 29, 2024 | Rosa David J. | President | M | Restricted Stock Units | 2253 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Rosa David J. | President | F | Common Stock | 763 | $386.59 | 217,792.0000 | 357,400,000 | 0.35% | 0.00% |
| Feb. 29, 2024 | Rosa David J. | President | M | Common Stock | 1504 | $0.00 | 218,555.0000 | 357,400,000 | 0.69% | 0.00% |
| Feb. 29, 2024 | Rosa David J. | President | F | Common Stock | 1142 | $386.59 | 217,051.0000 | 357,400,000 | 0.52% | 0.00% |
| Feb. 29, 2024 | Rosa David J. | President | M | Common Stock | 2253 | $0.00 | 218,193.0000 | 357,400,000 | 1.04% | 0.00% |
| Feb. 29, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1003 | $0.00 | 2,004.0000 | 357,400,000 | 33.36% | 0.00% |
| Feb. 29, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 2253 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 1142 | $386.59 | 1,903.0000 | 357,400,000 | 37.50% | 0.00% |
| Feb. 29, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2253 | $0.00 | 3,045.0000 | 357,400,000 | 284.47% | 0.00% |
| Feb. 29, 2024 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 509 | $386.59 | 792.0000 | 357,400,000 | 39.12% | 0.00% |
| Feb. 29, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1003 | $0.00 | 1,301.0000 | 357,400,000 | 336.58% | 0.00% |
| Feb. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 1504 | $0.00 | 3,007.0000 | 357,400,000 | 33.34% | 0.00% |
| Feb. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 2172 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 697 | $386.59 | 11,075.0000 | 357,400,000 | 5.92% | 0.00% |
| Feb. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1504 | $0.00 | 11,772.0000 | 357,400,000 | 14.65% | 0.00% |
| Feb. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 1003 | $386.59 | 10,268.0000 | 357,400,000 | 8.90% | 0.00% |
| Feb. 29, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 2172 | $0.00 | 11,271.0000 | 357,400,000 | 23.87% | 0.00% |
| Feb. 29, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Restricted Stock Units | 1449 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Restricted Stock Units | 752 | $0.00 | 1,504.0000 | 357,400,000 | 33.33% | 0.00% |
| Feb. 29, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | F | Common Stock | 338 | $386.59 | 23,486.0000 | 357,400,000 | 1.42% | 0.00% |
| Feb. 29, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 752 | $0.00 | 23,824.0000 | 357,400,000 | 3.26% | 0.00% |
| Feb. 29, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | F | Common Stock | 642 | $386.59 | 23,072.0000 | 357,400,000 | 2.71% | 0.00% |
| Feb. 29, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 1449 | $0.00 | 23,714.0000 | 357,400,000 | 6.51% | 0.00% |
| Feb. 29, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 1003 | $0.00 | 2,004.0000 | 357,400,000 | 33.36% | 0.00% |
| Feb. 29, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 2253 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 13530 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 10500 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 13530 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 12750 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 10500 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 12750 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 22500 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 22500 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 11250 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 509 | $386.59 | 149,855.0000 | 357,400,000 | 0.34% | 0.00% |
| Feb. 29, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 1003 | $0.00 | 150,364.0000 | 357,400,000 | 0.67% | 0.00% |
| Feb. 29, 2024 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 1142 | $386.59 | 149,361.0000 | 357,400,000 | 0.76% | 0.00% |
| Feb. 29, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 2253 | $0.00 | 150,503.0000 | 357,400,000 | 1.52% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 10500 | $385.08 | 148,250.0000 | 357,400,000 | 6.61% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 10500 | $182.83 | 158,750.0000 | 357,400,000 | 7.08% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 6860 | $385.08 | 148,250.0000 | 357,400,000 | 4.42% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 11250 | $77.00 | 155,110.0000 | 357,400,000 | 7.82% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 13750 | $385.08 | 143,860.0000 | 357,400,000 | 8.72% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 22500 | $79.64 | 157,610.0000 | 357,400,000 | 16.65% | 0.01% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 14620 | $385.09 | 135,110.0000 | 357,400,000 | 9.76% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 22500 | $109.49 | 149,730.0000 | 357,400,000 | 17.68% | 0.01% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 12750 | $385.08 | 127,230.0000 | 357,400,000 | 9.11% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 12750 | $139.52 | 139,980.0000 | 357,400,000 | 10.02% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 12750 | $385.08 | 127,230.0000 | 357,400,000 | 9.11% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 12750 | $174.26 | 139,980.0000 | 357,400,000 | 10.02% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 10500 | $385.08 | 127,230.0000 | 357,400,000 | 7.62% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 10500 | $166.62 | 137,730.0000 | 357,400,000 | 8.25% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 13530 | $385.08 | 127,230.0000 | 357,400,000 | 9.61% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 13530 | $177.99 | 140,760.0000 | 357,400,000 | 10.63% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 13530 | $385.08 | 127,230.0000 | 357,400,000 | 9.61% | 0.00% |
| Feb. 28, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 13530 | $242.34 | 140,760.0000 | 357,400,000 | 10.63% | 0.00% |
| Feb. 29, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-28-2022 | 1128 | $0.00 | 2,255.0000 | 357,400,000 | 33.34% | 0.00% |
| Feb. 29, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-28-2020 | 1689 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Feb. 26, 2024 | Rosa David J. | President | M | Common Stock | 1710 | $0.00 | 216,807.0000 | 357,400,000 | 0.79% | 0.00% |
| Feb. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 1587 | $0.00 | 9,597.0000 | 357,400,000 | 19.81% | 0.00% |
| Feb. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 498 | $389.77 | 9,099.0000 | 357,400,000 | 5.19% | 0.00% |
| Feb. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 1587 | $0.00 | 1,587.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | A | Restricted Stock Units - 2-26-2024 | 6105 | $0.00 | 6,105.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Common Stock | 855 | $0.00 | 1,564.0000 | 357,400,000 | 120.59% | 0.00% |
| Feb. 26, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | F | Common Stock | 434 | $389.77 | 1,130.0000 | 357,400,000 | 27.75% | 0.00% |
| Feb. 26, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | Restricted Stock Units - 2-26-2021 | 855 | $0.00 | 855.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | A | Restricted Stock Units - 2-26-2024 | 6487 | $0.00 | 6,487.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1710 | $0.00 | 2,008.0000 | 357,400,000 | 573.83% | 0.00% |
| Feb. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 867 | $389.77 | 1,141.0000 | 357,400,000 | 43.18% | 0.00% |
| Feb. 27, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 843 | $386.46 | 298.0000 | 357,400,000 | 73.88% | 0.00% |
| Feb. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1710 | $0.00 | 1,710.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | A | Restricted Stock Units - 2-26-2024 | 9158 | $0.00 | 9,158.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1650 | $0.00 | 11,432.0000 | 357,400,000 | 16.87% | 0.00% |
| Feb. 26, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 649 | $389.77 | 10,783.0000 | 357,400,000 | 5.68% | 0.00% |
| Feb. 26, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units - 2-26-2021 | 1650 | $0.00 | 1,647.0000 | 357,400,000 | 50.05% | 0.00% |
| Feb. 26, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | A | Restricted Stock Units - 2-26-2024 | 6487 | $0.00 | 6,487.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 1710 | $0.00 | 128,097.0000 | 357,400,000 | 1.35% | 0.00% |
| Feb. 26, 2024 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 867 | $389.77 | 127,230.0000 | 357,400,000 | 0.68% | 0.00% |
| Feb. 26, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 1710 | $0.00 | 1,710.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | Samath Jamie | Chief Financial Officer | M | Common Stock | 1284 | $0.00 | 8,197.0000 | 357,400,000 | 18.57% | 0.00% |
| Feb. 26, 2024 | Samath Jamie | Chief Financial Officer | F | Common Stock | 459 | $389.77 | 7,738.0000 | 357,400,000 | 5.60% | 0.00% |
| Feb. 26, 2024 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 1284 | $0.00 | 1,281.0000 | 357,400,000 | 50.06% | 0.00% |
| Feb. 26, 2024 | Samath Jamie | Chief Financial Officer | A | Restricted Stock Units - 2-26-2024 | 7631 | $0.00 | 7,631.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Rosa David J. | President | F | Common Stock | 867 | $389.77 | 215,940.0000 | 357,400,000 | 0.40% | 0.00% |
| Feb. 26, 2024 | Rosa David J. | President | M | Restricted Stock Units | 1710 | $0.00 | 1,710.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | Rosa David J. | President | A | Restricted Stock Units - 2-26-2024 | 15263 | $0.00 | 15,263.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 609 | $0.00 | 3,298.0000 | 357,400,000 | 22.65% | 0.00% |
| Feb. 26, 2024 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 218 | $389.77 | 3,080.0000 | 357,400,000 | 6.61% | 0.00% |
| Feb. 26, 2024 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 609 | $0.00 | 606.0000 | 357,400,000 | 50.12% | 0.00% |
| Feb. 26, 2024 | Widman Fredrik | VP Corporate Controller | A | Restricted Stock Units - 2-26-2024 | 2442 | $0.00 | 2,442.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | F | Common Stock | 384 | $389.77 | 22,265.0000 | 357,400,000 | 1.70% | 0.00% |
| Feb. 26, 2024 | GUTHART GARY S | CEO | M | Restricted Stock Units | 3030 | $0.00 | 3,030.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 26, 2024 | GUTHART GARY S | CEO | A | Restricted Stock Units - 2-26-2024 | 19841 | $0.00 | 19,841.0000 | 357,400,000 | 9999.99% | 0.01% |
| Feb. 26, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 1284 | $0.00 | 22,649.0000 | 357,400,000 | 6.01% | 0.00% |
| Feb. 26, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Restricted Stock Units | 1284 | $0.00 | 1,281.0000 | 357,400,000 | 50.06% | 0.00% |
| Feb. 26, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | A | Restricted Stock Units - 2-26-2024 | 6868 | $0.00 | 6,868.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | LOEB GARY | General Counsel | A | Restricted Stock Units - 2-26-2024 | 6105 | $0.00 | 6,105.0000 | 357,400,000 | 9999.99% | 0.00% |
| Feb. 26, 2024 | GUTHART GARY S | CEO | M | Common Stock | 3030 | $0.00 | 1,272,118.0000 | 357,400,000 | 0.24% | 0.00% |
| Feb. 26, 2024 | GUTHART GARY S | CEO | F | Common Stock | 1536 | $389.77 | 1,270,582.0000 | 357,400,000 | 0.12% | 0.00% |
| Feb. 14, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 30 | $380.09 | 771.0000 | 357,400,000 | 3.75% | 0.00% |
| Feb. 15, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 30 | $382.03 | 741.0000 | 357,400,000 | 3.89% | 0.00% |
| Feb. 16, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 32 | $378.29 | 709.0000 | 357,400,000 | 4.32% | 0.00% |
| Feb. 15, 2024 | Leonard Keith R | Director | G | Common Stock | 2547 | $0.00 | 1,037.0000 | 357,400,000 | 71.07% | 0.00% |
| Feb. 12, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 481 | $386.09 | 298.0000 | 357,400,000 | 61.75% | 0.00% |
| Feb. 10, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 838 | $0.00 | 2,514.0000 | 357,400,000 | 25.00% | 0.00% |
| Feb. 10, 2024 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 357 | $388.22 | 779.0000 | 357,400,000 | 31.43% | 0.00% |
| Feb. 10, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 838 | $0.00 | 1,136.0000 | 357,400,000 | 281.21% | 0.00% |
| Feb. 13, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 30 | $375.51 | 801.0000 | 357,400,000 | 3.61% | 0.00% |
| Feb. 12, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 30 | $386.09 | 831.0000 | 357,400,000 | 3.48% | 0.00% |
| Feb. 10, 2024 | Brosius Mark | See Remarks | M | Common Stock | 838 | $0.00 | 1,286.0000 | 357,400,000 | 187.05% | 0.00% |
| Feb. 10, 2024 | Rosa David J. | President | M | Restricted Stock Units | 1437 | $0.00 | 4,309.0000 | 357,400,000 | 25.01% | 0.00% |
| Feb. 10, 2024 | Rosa David J. | President | F | Common Stock | 729 | $388.22 | 215,097.0000 | 357,400,000 | 0.34% | 0.00% |
| Feb. 10, 2024 | Rosa David J. | President | M | Common Stock | 1437 | $0.00 | 215,826.0000 | 357,400,000 | 0.67% | 0.00% |
| Feb. 10, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | F | Common Stock | 487 | $388.22 | 9,782.0000 | 357,400,000 | 4.74% | 0.00% |
| Feb. 10, 2024 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 1085 | $388.22 | 126,387.0000 | 357,400,000 | 0.85% | 0.00% |
| Feb. 10, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 2873 | $0.00 | 2,873.0000 | 357,400,000 | 50.00% | 0.00% |
| Feb. 10, 2024 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 568 | $0.00 | 2,911.0000 | 357,400,000 | 24.24% | 0.00% |
| Feb. 10, 2024 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 222 | $388.22 | 2,689.0000 | 357,400,000 | 7.63% | 0.00% |
| Feb. 10, 2024 | LOEB GARY | General Counsel | M | Restricted Stock Units | 315 | $0.00 | 944.0000 | 357,400,000 | 25.02% | 0.00% |
| Feb. 10, 2024 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 568 | $0.00 | 1,702.0000 | 357,400,000 | 25.02% | 0.00% |
| Feb. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 958 | $0.00 | 8,326.0000 | 357,400,000 | 13.00% | 0.00% |
| Feb. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | F | Common Stock | 316 | $388.22 | 8,010.0000 | 357,400,000 | 3.80% | 0.00% |
| Feb. 10, 2024 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Restricted Stock Units | 958 | $0.00 | 2,873.0000 | 357,400,000 | 25.01% | 0.00% |
| Feb. 10, 2024 | LOEB GARY | General Counsel | F | Common Stock | 129 | $388.22 | 1,895.0000 | 357,400,000 | 6.37% | 0.00% |
| Feb. 10, 2024 | LOEB GARY | General Counsel | M | Common Stock | 315 | $0.00 | 2,024.0000 | 357,400,000 | 18.43% | 0.00% |
| Feb. 10, 2024 | GUTHART GARY S | CEO | F | Common Stock | 1335 | $388.22 | 1,269,088.0000 | 357,400,000 | 0.11% | 0.00% |
| Feb. 10, 2024 | GUTHART GARY S | CEO | M | Restricted Stock Units | 2634 | $0.00 | 7,900.0000 | 357,400,000 | 25.00% | 0.00% |
| Feb. 10, 2024 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 2873 | $0.00 | 127,472.0000 | 357,400,000 | 2.31% | 0.00% |
| Feb. 10, 2024 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 1078 | $0.00 | 3,232.0000 | 357,400,000 | 25.01% | 0.00% |
| Feb. 10, 2024 | Samath Jamie | Chief Financial Officer | F | Common Stock | 401 | $388.22 | 6,913.0000 | 357,400,000 | 5.48% | 0.00% |
| Feb. 10, 2024 | Samath Jamie | Chief Financial Officer | M | Common Stock | 1078 | $0.00 | 7,314.0000 | 357,400,000 | 17.29% | 0.00% |
| Feb. 10, 2024 | Brosius Mark | See Remarks | M | Restricted Stock Units | 838 | $0.00 | 2,514.0000 | 357,400,000 | 25.00% | 0.00% |
| Feb. 10, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Restricted Stock Units | 1317 | $0.00 | 3,950.0000 | 357,400,000 | 25.00% | 0.00% |
| Feb. 10, 2024 | GUTHART GARY S | CEO | M | Common Stock | 2634 | $0.00 | 1,270,423.0000 | 357,400,000 | 0.21% | 0.00% |
| Feb. 10, 2024 | Miller Brian Edward | EVP & Chief Digital Officer | M | Common Stock | 1317 | $0.00 | 10,269.0000 | 357,400,000 | 14.71% | 0.00% |
| Feb. 10, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Common Stock | 1078 | $0.00 | 21,703.0000 | 357,400,000 | 5.23% | 0.00% |
| Feb. 10, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | F | Common Stock | 338 | $388.22 | 21,365.0000 | 357,400,000 | 1.56% | 0.00% |
| Feb. 10, 2024 | Charlton Henry L | SVP & Chief Commercial and Mkt | M | Restricted Stock Units | 1078 | $0.00 | 3,232.0000 | 357,400,000 | 25.01% | 0.00% |
| Feb. 10, 2024 | Brosius Mark | See Remarks | F | Common Stock | 425 | $388.22 | 861.0000 | 357,400,000 | 33.05% | 0.00% |
| Feb. 7, 2024 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 40500 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | M | Common Stock | 22050 | $59.23 | 176,299.0000 | 357,400,000 | 14.30% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | S | Common Stock | 12900 | $389.29 | 163,399.0000 | 357,400,000 | 7.32% | 0.00% |
| Feb. 7, 2024 | Rosa David J. | President | M | Common Stock | 22050 | $57.11 | 185,449.0000 | 357,400,000 | 13.49% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | S | Common Stock | 12840 | $389.30 | 172,609.0000 | 357,400,000 | 6.92% | 0.00% |
| Feb. 7, 2024 | Rosa David J. | President | M | Common Stock | 28125 | $51.02 | 200,734.0000 | 357,400,000 | 16.29% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | S | Common Stock | 16150 | $389.23 | 184,584.0000 | 357,400,000 | 8.05% | 0.00% |
| Feb. 7, 2024 | Rosa David J. | President | M | Common Stock | 40500 | $49.09 | 225,084.0000 | 357,400,000 | 21.94% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | S | Common Stock | 23120 | $389.28 | 201,964.0000 | 357,400,000 | 10.27% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | M | Common Stock | 28125 | $49.34 | 230,089.0000 | 357,400,000 | 13.93% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | S | Common Stock | 15700 | $389.29 | 214,389.0000 | 357,400,000 | 6.82% | 0.00% |
| Feb. 7, 2024 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 28125 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 28125 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 22050 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 7, 2024 | Rosa David J. | President | M | Non-Qualified Stock Option (right to buy) | 22050 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Feb. 1, 2024 | Brosius Mark | SVP & Chief Mfg and Supply Cha | S | Common Stock | 39 | $378.41 | 448.0000 | 357,400,000 | 8.01% | 0.00% |
| Jan. 29, 2024 | GUTHART GARY S | CEO | M | Non-Qualified Stock Option (right to buy) | 33750 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.01% |
| Jan. 29, 2024 | GUTHART GARY S | CEO | S | Common Stock | 2480 | $374.41 | 1,267,789.0000 | 357,400,000 | 0.20% | 0.00% |
| Jan. 29, 2024 | GUTHART GARY S | CEO | S | Common Stock | 2480 | $374.41 | 1,267,789.0000 | 357,400,000 | 0.20% | 0.00% |
| Jan. 29, 2024 | GUTHART GARY S | CEO | S | Common Stock | 24325 | $376.06 | 1,267,789.0000 | 357,400,000 | 1.88% | 0.01% |
| Jan. 29, 2024 | GUTHART GARY S | CEO | M | Common Stock | 33750 | $51.02 | 1,292,114.0000 | 357,400,000 | 2.68% | 0.01% |
| Jan. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 1500 | $0.00 | 7,500.0000 | 357,400,000 | 16.67% | 0.00% |
| Jan. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2818 | $0.00 | 7,893.0000 | 357,400,000 | 26.31% | 0.00% |
| Jan. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1500 | $370.15 | 189.0000 | 357,400,000 | 88.81% | 0.00% |
| Jan. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1500 | $182.83 | 1,689.0000 | 357,400,000 | 793.65% | 0.00% |
| Jan. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2818 | $370.15 | 189.0000 | 357,400,000 | 93.71% | 0.00% |
| Jan. 26, 2024 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2818 | $177.99 | 3,007.0000 | 357,400,000 | 1491.01% | 0.00% |
| Jan. 26, 2024 | LEVY ALAN J | Director | M | Common Stock | 72 | $154.24 | 25,391.0000 | 357,400,000 | 0.28% | 0.00% |
| Jan. 26, 2024 | Johnson Amal M | Director | M | Non-Qualified Stock Option (right to buy) | 6696 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Jan. 26, 2024 | LEVY ALAN J | Director | S | Common Stock | 72 | $370.20 | 25,319.0000 | 357,400,000 | 0.28% | 0.00% |
| Jan. 26, 2024 | LEVY ALAN J | Director | M | Common Stock | 1928 | $90.49 | 27,247.0000 | 357,400,000 | 7.61% | 0.00% |
| Jan. 26, 2024 | LEVY ALAN J | Director | S | Common Stock | 1928 | $370.20 | 25,319.0000 | 357,400,000 | 7.08% | 0.00% |
| Jan. 26, 2024 | LEVY ALAN J | Director | M | Non-Qualified Stock Option (right to buy) | 1928 | $0.00 | 0.0000 | 357,400,000 | 100.00% | 0.00% |
| Jan. 26, 2024 | LEVY ALAN J | Director | M | Non-Qualified Stock Option (right to buy) | 72 | $0.00 | 2,916.0000 | 357,400,000 | 2.41% | 0.00% |
| Jan. 26, 2024 | Johnson Amal M | Director | M | Common Stock | 6696 | $56.97 | 18,402.0000 | 357,400,000 | 57.20% | 0.00% |
| Jan. 26, 2024 | Johnson Amal M | Director | S | Common Stock | 6696 | $370.08 | 11,706.0000 | 357,400,000 | 36.39% | 0.00% |
| Dec. 13, 2023 | Rosa David J. | President | G | Common Stock | 1572 | $0.00 | 154,140.0000 | 362,000,000 | 1.01% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 1500 | $0.00 | 9,000.0000 | 362,000,000 | 14.29% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2819 | $0.00 | 10,711.0000 | 362,000,000 | 20.84% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 4500 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1500 | $300.00 | 189.0000 | 362,000,000 | 88.81% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1500 | $182.83 | 1,689.0000 | 362,000,000 | 793.65% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 4500 | $166.62 | 4,689.0000 | 362,000,000 | 2380.95% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2819 | $300.00 | 189.0000 | 362,000,000 | 93.72% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2819 | $177.99 | 3,008.0000 | 362,000,000 | 1491.53% | 0.00% |
| Nov. 16, 2023 | Johnson Amal M | Director | M | Non-Qualified Stock Option (right to buy) | 9567 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Nov. 16, 2023 | Johnson Amal M | Director | S | Common Stock | 9567 | $300.00 | 11,706.0000 | 362,000,000 | 44.97% | 0.00% |
| Nov. 16, 2023 | Johnson Amal M | Director | M | Common Stock | 9567 | $41.26 | 21,273.0000 | 362,000,000 | 81.73% | 0.00% |
| Nov. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 4500 | $300.00 | 189.0000 | 362,000,000 | 95.97% | 0.00% |
| Nov. 14, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 597 | $290.00 | 7,259.0000 | 362,000,000 | 7.60% | 0.00% |
| Nov. 14, 2023 | LEVY ALAN J | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 1,928.0000 | 362,000,000 | 50.92% | 0.00% |
| Nov. 14, 2023 | LEVY ALAN J | Director | S | Common Stock | 2000 | $290.00 | 25,319.0000 | 362,000,000 | 7.32% | 0.00% |
| Nov. 14, 2023 | LEVY ALAN J | Director | M | Common Stock | 2000 | $90.49 | 27,319.0000 | 362,000,000 | 7.90% | 0.00% |
| Nov. 14, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 597 | $0.00 | 3,375.0000 | 362,000,000 | 15.03% | 0.00% |
| Nov. 14, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 270 | $0.00 | 453.0000 | 362,000,000 | 37.34% | 0.00% |
| Nov. 14, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 270 | $290.00 | 7,259.0000 | 362,000,000 | 3.59% | 0.00% |
| Nov. 14, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 270 | $242.34 | 7,529.0000 | 362,000,000 | 3.72% | 0.00% |
| Nov. 14, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 597 | $245.60 | 7,856.0000 | 362,000,000 | 8.22% | 0.00% |
| Nov. 10, 2023 | Kolli Sreelakshmi | Director | A | Non-Qualified Stock Option (right to buy) | 722 | $0.00 | 722.0000 | 362,000,000 | 9999.99% | 0.00% |
| Nov. 10, 2023 | Kolli Sreelakshmi | Director | A | Restricted Stock Units | 240 | $0.00 | 240.0000 | 362,000,000 | 9999.99% | 0.00% |
| Oct. 24, 2023 | GUTHART GARY S | CEO | S | Common Stock | 2480 | $271.93 | 1,263,324.0000 | 362,000,000 | 0.20% | 0.00% |
| Oct. 26, 2023 | GUTHART GARY S | CEO | M | Common Stock | 33750 | $49.34 | 1,290,709.0000 | 362,000,000 | 2.69% | 0.01% |
| Oct. 26, 2023 | GUTHART GARY S | CEO | M | Non-Qualified Stock Option (right to buy) | 33750 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.01% |
| Oct. 24, 2023 | GUTHART GARY S | CEO | S | Common Stock | 2480 | $271.93 | 1,263,324.0000 | 362,000,000 | 0.20% | 0.00% |
| Oct. 26, 2023 | GUTHART GARY S | CEO | S | Common Stock | 27385 | $260.11 | 1,263,324.0000 | 362,000,000 | 2.12% | 0.01% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 273 | $0.00 | 633.0000 | 362,000,000 | 30.13% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 273 | $179.70 | 7,532.0000 | 362,000,000 | 3.76% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 273 | $271.93 | 7,259.0000 | 362,000,000 | 3.62% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 273 | $177.99 | 7,532.0000 | 362,000,000 | 3.76% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 273 | $271.93 | 7,259.0000 | 362,000,000 | 3.62% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 564 | $208.90 | 7,823.0000 | 362,000,000 | 7.77% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 564 | $275.00 | 7,259.0000 | 362,000,000 | 7.21% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 273 | $0.00 | 453.0000 | 362,000,000 | 37.60% | 0.00% |
| Oct. 24, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 564 | $0.00 | 5,451.0000 | 362,000,000 | 9.38% | 0.00% |
| Oct. 10, 2023 | LOEB GARY | General Counsel | M | Common Stock | 2613 | $0.00 | 2,613.0000 | 362,000,000 | 9999.99% | 0.00% |
| Oct. 10, 2023 | LOEB GARY | General Counsel | M | Restricted Stock Units | 2613 | $0.00 | 7,837.0000 | 362,000,000 | 25.00% | 0.00% |
| Oct. 10, 2023 | LOEB GARY | General Counsel | F | Common Stock | 904 | $297.83 | 1,709.0000 | 362,000,000 | 34.60% | 0.00% |
| Sept. 14, 2023 | Ladd Amy L | Director | S | Common Stock | 500 | $305.68 | 702.0000 | 362,000,000 | 41.60% | 0.00% |
| Aug. 10, 2023 | MOHR MARSHALL | Executive VP Global Business S | A | Non-Qualified Stock Option (right to buy) | 2873 | $0.00 | 2,873.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Charlton Henry L | SVP & Chief Commercial and Mkt | A | Non-Qualified Stock Option (right to buy) | 6464 | $0.00 | 6,464.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Widman Fredrik | VP Corporate Controller | A | Non-Qualified Stock Option (right to buy) | 1135 | $0.00 | 1,135.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Samath Jamie | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 6464 | $0.00 | 6,464.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Curet Myriam | EVP & Chief Medical Officer | A | Non-Qualified Stock Option (right to buy) | 5028 | $0.00 | 5,028.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | GUTHART GARY S | CEO | A | Non-Qualified Stock Option (right to buy) | 15801 | $0.00 | 15,801.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | A | Non-Qualified Stock Option (right to buy) | 5746 | $0.00 | 5,746.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | LOEB GARY | General Counsel | A | Non-Qualified Stock Option (right to buy) | 1889 | $0.00 | 1,889.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 10, 2023 | Rosa David J. | President | A | Non-Qualified Stock Option (right to buy) | 8619 | $0.00 | 8,619.0000 | 362,000,000 | 9999.99% | 0.00% |
| Aug. 7, 2023 | LEVY ALAN J | Director | S | Common Stock | 1535 | $310.00 | 25,319.0000 | 362,000,000 | 5.72% | 0.00% |
| Aug. 7, 2023 | LEVY ALAN J | Director | M | Common Stock | 465 | $71.32 | 25,784.0000 | 362,000,000 | 1.84% | 0.00% |
| Aug. 7, 2023 | LEVY ALAN J | Director | S | Common Stock | 465 | $310.00 | 25,319.0000 | 362,000,000 | 1.80% | 0.00% |
| Aug. 7, 2023 | LEVY ALAN J | Director | M | Non-Qualified Stock Option (right to buy) | 465 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Aug. 7, 2023 | LEVY ALAN J | Director | M | Non-Qualified Stock Option (right to buy) | 1535 | $0.00 | 3,928.0000 | 362,000,000 | 28.10% | 0.00% |
| Aug. 7, 2023 | LEVY ALAN J | Director | M | Common Stock | 1535 | $90.49 | 26,854.0000 | 362,000,000 | 6.06% | 0.00% |
| July 28, 2023 | GUTHART GARY S | CEO | G | Common Stock | 16000 | $0.00 | 1,261,919.0000 | 362,000,000 | 1.25% | 0.00% |
| July 28, 2023 | GUTHART GARY S | CEO | M | Common Stock | 67500 | $42.64 | 1,312,233.0000 | 362,000,000 | 5.42% | 0.02% |
| July 28, 2023 | GUTHART GARY S | CEO | S | Common Stock | 50314 | $326.76 | 1,261,919.0000 | 362,000,000 | 3.83% | 0.01% |
| July 31, 2023 | GUTHART GARY S | CEO | S | Common Stock | 2480 | $325.89 | 1,261,919.0000 | 362,000,000 | 0.20% | 0.00% |
| July 31, 2023 | GUTHART GARY S | CEO | S | Common Stock | 2480 | $325.89 | 1,261,919.0000 | 362,000,000 | 0.20% | 0.00% |
| July 28, 2023 | GUTHART GARY S | CEO | M | Non-Qualified Stock Option (right to buy) | 67500 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.02% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 270 | $0.00 | 726.0000 | 362,000,000 | 27.11% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 270 | $0.00 | 906.0000 | 362,000,000 | 22.96% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 564 | $0.00 | 6,015.0000 | 362,000,000 | 8.57% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 273 | $0.00 | 723.0000 | 362,000,000 | 27.41% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 594 | $0.00 | 3,972.0000 | 362,000,000 | 13.01% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Non-Qualified Stock Option (right to buy) | 564 | $0.00 | 6,016.0000 | 362,000,000 | 8.57% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 564 | $290.33 | 7,823.0000 | 362,000,000 | 7.77% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 564 | $325.00 | 7,259.0000 | 362,000,000 | 7.21% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 594 | $245.60 | 7,853.0000 | 362,000,000 | 8.18% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 594 | $322.76 | 7,259.0000 | 362,000,000 | 7.56% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 273 | $242.34 | 7,532.0000 | 362,000,000 | 3.76% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 273 | $322.76 | 7,259.0000 | 362,000,000 | 3.62% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 270 | $179.70 | 7,529.0000 | 362,000,000 | 3.72% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 270 | $322.76 | 7,259.0000 | 362,000,000 | 3.59% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 270 | $177.99 | 7,529.0000 | 362,000,000 | 3.72% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 270 | $322.76 | 7,259.0000 | 362,000,000 | 3.59% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | M | Common Stock | 564 | $208.90 | 7,823.0000 | 362,000,000 | 7.77% | 0.00% |
| July 25, 2023 | DeSantis Robert | EVP & Chief Strategy & Corp Op | S | Common Stock | 564 | $322.76 | 7,259.0000 | 362,000,000 | 7.21% | 0.00% |
| June 14, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 2443 | $0.00 | 6,580.0000 | 362,000,000 | 27.08% | 0.00% |
| June 12, 2023 | Rosa David J. | President | A | Restricted Stock Units | 5433 | $0.00 | 5,433.0000 | 362,000,000 | 9999.99% | 0.00% |
| June 14, 2023 | BARRATT CRAIG H | Director | M | Common Stock | 1567 | $41.26 | 26,918.0000 | 362,000,000 | 6.18% | 0.00% |
| June 14, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 11250 | $59.46 | 135,739.0000 | 362,000,000 | 9.04% | 0.00% |
| June 14, 2023 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 11250 | $325.00 | 124,489.0000 | 362,000,000 | 8.29% | 0.00% |
| June 14, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 11250 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| June 14, 2023 | BARRATT CRAIG H | Director | S | Common Stock | 1567 | $322.78 | 25,351.0000 | 362,000,000 | 5.82% | 0.00% |
| June 14, 2023 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 1567 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| June 14, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 2443 | $290.33 | 9,702.0000 | 362,000,000 | 33.65% | 0.00% |
| June 14, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 2443 | $325.00 | 7,259.0000 | 362,000,000 | 25.18% | 0.00% |
| June 12, 2023 | Rosa David J. | President | A | Non-Qualified Stock Option (right to buy) | 16297 | $0.00 | 16,297.0000 | 362,000,000 | 9999.99% | 0.00% |
| May 11, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 363 | $0.00 | 7,428.0000 | 362,000,000 | 5.14% | 0.00% |
| May 11, 2023 | DeSantis Robert | EVP & Chief Product Officer | F | Common Stock | 169 | $303.47 | 7,259.0000 | 362,000,000 | 2.28% | 0.00% |
| May 11, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Restricted Stock Units | 363 | $0.00 | 360.0000 | 362,000,000 | 50.21% | 0.00% |
| May 2, 2023 | Curet Myriam | EVP & Chief Medical Officer | G | Common Stock | 138 | $0.00 | 189.0000 | 362,000,000 | 42.20% | 0.00% |
| May 1, 2023 | BARRATT CRAIG H | Director | M | Common Stock | 2000 | $41.26 | 27,351.0000 | 362,000,000 | 7.89% | 0.00% |
| May 1, 2023 | BARRATT CRAIG H | Director | S | Common Stock | 2000 | $306.00 | 25,351.0000 | 362,000,000 | 7.31% | 0.00% |
| May 1, 2023 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 1,567.0000 | 362,000,000 | 56.07% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 895 | $154.24 | 16,377.0000 | 362,000,000 | 5.78% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 895 | $300.00 | 15,482.0000 | 362,000,000 | 5.46% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 1391 | $90.49 | 16,873.0000 | 362,000,000 | 8.98% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 1391 | $300.00 | 15,482.0000 | 362,000,000 | 8.24% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 523 | $71.32 | 16,005.0000 | 362,000,000 | 3.38% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 523 | $300.00 | 15,482.0000 | 362,000,000 | 3.27% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 1391 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 895 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 688 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 707 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 1448 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 1671 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 523 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 1448 | $243.26 | 16,930.0000 | 362,000,000 | 9.35% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 1448 | $300.00 | 15,482.0000 | 362,000,000 | 8.55% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 1671 | $286.55 | 17,153.0000 | 362,000,000 | 10.79% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 688 | $171.07 | 16,170.0000 | 362,000,000 | 4.44% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 1671 | $300.00 | 15,482.0000 | 362,000,000 | 9.74% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 688 | $300.00 | 15,482.0000 | 362,000,000 | 4.25% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | M | Common Stock | 707 | $172.59 | 16,189.0000 | 362,000,000 | 4.57% | 0.00% |
| April 28, 2023 | RUBASH MARK J | Director | S | Common Stock | 707 | $300.00 | 15,482.0000 | 362,000,000 | 4.37% | 0.00% |
| April 27, 2023 | LEVY ALAN J | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Leonard Keith R | Director | M | Common Stock | 482 | $0.00 | 3,584.0000 | 362,000,000 | 15.54% | 0.00% |
| April 27, 2023 | Leonard Keith R | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Leonard Keith R | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | Leonard Keith R | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Beery Joseph C | Director | M | Common Stock | 482 | $0.00 | 1,802.0000 | 362,000,000 | 36.52% | 0.00% |
| April 27, 2023 | Beery Joseph C | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Beery Joseph C | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | Beery Joseph C | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | BARRATT CRAIG H | Director | M | Common Stock | 655 | $0.00 | 25,351.0000 | 362,000,000 | 2.65% | 0.00% |
| April 27, 2023 | BARRATT CRAIG H | Director | A | Non-Qualified Stock Option (right to buy) | 2412 | $0.00 | 2,412.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | BARRATT CRAIG H | Director | M | Restricted Stock Units | 655 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | BARRATT CRAIG H | Director | A | Restricted Stock Units | 804 | $0.00 | 804.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Johnson Amal M | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Johnson Amal M | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Johnson Amal M | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | Johnson Amal M | Director | M | Common Stock | 482 | $0.00 | 11,706.0000 | 362,000,000 | 4.29% | 0.00% |
| April 27, 2023 | KANIA DON R | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | KANIA DON R | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | KANIA DON R | Director | M | Common Stock | 482 | $0.00 | 3,269.0000 | 362,000,000 | 17.29% | 0.00% |
| April 27, 2023 | KANIA DON R | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | RUBASH MARK J | Director | M | Common Stock | 482 | $0.00 | 15,482.0000 | 362,000,000 | 3.21% | 0.00% |
| April 27, 2023 | RUBASH MARK J | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | RUBASH MARK J | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | RUBASH MARK J | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Reed Monica P | Director | M | Common Stock | 482 | $0.00 | 1,037.0000 | 362,000,000 | 86.85% | 0.00% |
| April 27, 2023 | Reed Monica P | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Reed Monica P | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | Reed Monica P | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | NACHTSHEIM JAMI K | Director | M | Common Stock | 482 | $0.00 | 5,063.0000 | 362,000,000 | 10.52% | 0.00% |
| April 27, 2023 | NACHTSHEIM JAMI K | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | NACHTSHEIM JAMI K | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | NACHTSHEIM JAMI K | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Ladd Amy L | Director | M | Common Stock | 482 | $0.00 | 1,202.0000 | 362,000,000 | 66.94% | 0.00% |
| April 27, 2023 | Ladd Amy L | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | Ladd Amy L | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 27, 2023 | Ladd Amy L | Director | A | Restricted Stock Units | 569 | $0.00 | 569.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | LEVY ALAN J | Director | M | Common Stock | 482 | $0.00 | 25,319.0000 | 362,000,000 | 1.94% | 0.00% |
| April 27, 2023 | LEVY ALAN J | Director | A | Non-Qualified Stock Option (right to buy) | 1709 | $0.00 | 1,709.0000 | 362,000,000 | 9999.99% | 0.00% |
| April 27, 2023 | LEVY ALAN J | Director | M | Restricted Stock Units | 482 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 349 | $297.94 | 15,000.0000 | 362,000,000 | 2.27% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 6000 | $300.00 | 1,950.0000 | 362,000,000 | 75.47% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1118 | $297.92 | 832.0000 | 362,000,000 | 57.33% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 505 | $300.00 | 327.0000 | 362,000,000 | 60.70% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 4,500.0000 | 362,000,000 | 30.77% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 6000 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 2000 | $300.00 | 1,950.0000 | 362,000,000 | 50.63% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2000 | $166.62 | 3,950.0000 | 362,000,000 | 102.56% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 3,567.0000 | 362,000,000 | 35.93% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 5,567.0000 | 362,000,000 | 26.43% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | M | Non-Qualified Stock Option (right to buy) | 2000 | $0.00 | 7,567.0000 | 362,000,000 | 20.91% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | S | Common Stock | 2000 | $297.92 | 24,696.0000 | 362,000,000 | 7.49% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | M | Common Stock | 2000 | $41.26 | 26,696.0000 | 362,000,000 | 8.10% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | S | Common Stock | 2000 | $297.93 | 24,696.0000 | 362,000,000 | 7.49% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | M | Common Stock | 2000 | $41.26 | 26,696.0000 | 362,000,000 | 8.10% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | S | Common Stock | 2000 | $297.92 | 24,696.0000 | 362,000,000 | 7.49% | 0.00% |
| April 21, 2023 | BARRATT CRAIG H | Director | M | Common Stock | 2000 | $41.26 | 26,696.0000 | 362,000,000 | 8.10% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 2184 | $0.00 | 4,566.0000 | 362,000,000 | 32.36% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 1086 | $0.00 | 996.0000 | 362,000,000 | 52.16% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 2444 | $0.00 | 6,579.0000 | 362,000,000 | 27.09% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 273 | $0.00 | 1,176.0000 | 362,000,000 | 18.84% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 273 | $0.00 | 996.0000 | 362,000,000 | 21.51% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 1167 | $297.90 | 7,065.0000 | 362,000,000 | 14.18% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 1196 | $297.91 | 8,232.0000 | 362,000,000 | 12.69% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 2444 | $297.93 | 9,428.0000 | 362,000,000 | 20.59% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 2444 | $208.90 | 11,872.0000 | 362,000,000 | 25.92% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 273 | $298.00 | 9,428.0000 | 362,000,000 | 2.81% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 273 | $177.99 | 9,701.0000 | 362,000,000 | 2.90% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 273 | $298.00 | 9,428.0000 | 362,000,000 | 2.81% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 273 | $179.70 | 9,701.0000 | 362,000,000 | 2.90% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 1086 | $297.92 | 9,428.0000 | 362,000,000 | 10.33% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 1086 | $242.34 | 10,514.0000 | 362,000,000 | 11.52% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 2184 | $297.92 | 9,428.0000 | 362,000,000 | 18.81% | 0.00% |
| April 21, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 2184 | $245.60 | 11,612.0000 | 362,000,000 | 23.17% | 0.00% |
| April 21, 2023 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 630 | $297.87 | 2,233.0000 | 362,000,000 | 22.00% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 927 | $297.94 | 15,000.0000 | 362,000,000 | 5.82% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 927 | $90.49 | 15,927.0000 | 362,000,000 | 6.18% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 927 | $297.93 | 15,000.0000 | 362,000,000 | 5.82% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 927 | $90.49 | 15,927.0000 | 362,000,000 | 6.18% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 927 | $297.94 | 15,000.0000 | 362,000,000 | 5.82% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 927 | $90.49 | 15,927.0000 | 362,000,000 | 6.18% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 299 | $297.89 | 15,000.0000 | 362,000,000 | 1.95% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 299 | $154.24 | 15,299.0000 | 362,000,000 | 1.99% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 598 | $297.94 | 15,000.0000 | 362,000,000 | 3.83% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 598 | $154.24 | 15,598.0000 | 362,000,000 | 3.99% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 598 | $297.93 | 15,000.0000 | 362,000,000 | 3.83% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 598 | $154.24 | 15,598.0000 | 362,000,000 | 3.99% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 598 | $297.94 | 15,000.0000 | 362,000,000 | 3.83% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 598 | $154.24 | 15,598.0000 | 362,000,000 | 3.99% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 235 | $297.89 | 15,000.0000 | 362,000,000 | 1.54% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 235 | $172.59 | 15,235.0000 | 362,000,000 | 1.57% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 472 | $297.94 | 15,000.0000 | 362,000,000 | 3.05% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 472 | $172.59 | 15,472.0000 | 362,000,000 | 3.15% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 472 | $297.93 | 15,000.0000 | 362,000,000 | 3.05% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 472 | $172.59 | 15,472.0000 | 362,000,000 | 3.15% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 472 | $297.94 | 15,000.0000 | 362,000,000 | 3.05% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 472 | $172.59 | 15,472.0000 | 362,000,000 | 3.15% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 230 | $297.89 | 15,000.0000 | 362,000,000 | 1.51% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 230 | $171.07 | 15,230.0000 | 362,000,000 | 1.53% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 460 | $297.94 | 15,000.0000 | 362,000,000 | 2.98% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 460 | $171.07 | 15,460.0000 | 362,000,000 | 3.07% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 460 | $297.93 | 15,000.0000 | 362,000,000 | 2.98% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 460 | $171.07 | 15,460.0000 | 362,000,000 | 3.07% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 460 | $297.94 | 15,000.0000 | 362,000,000 | 2.98% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 460 | $171.07 | 15,460.0000 | 362,000,000 | 3.07% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 235 | $0.00 | 707.0000 | 362,000,000 | 24.95% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 472 | $0.00 | 942.0000 | 362,000,000 | 33.38% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 472 | $0.00 | 1,414.0000 | 362,000,000 | 25.03% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 472 | $0.00 | 1,886.0000 | 362,000,000 | 20.02% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 230 | $0.00 | 688.0000 | 362,000,000 | 25.05% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 460 | $0.00 | 918.0000 | 362,000,000 | 33.38% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 460 | $0.00 | 1,378.0000 | 362,000,000 | 25.03% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 460 | $0.00 | 1,838.0000 | 362,000,000 | 20.02% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 299 | $0.00 | 895.0000 | 362,000,000 | 25.04% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 598 | $0.00 | 1,194.0000 | 362,000,000 | 33.37% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 598 | $0.00 | 1,792.0000 | 362,000,000 | 25.02% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 598 | $0.00 | 2,390.0000 | 362,000,000 | 20.01% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 463 | $0.00 | 1,391.0000 | 362,000,000 | 24.97% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 927 | $0.00 | 1,854.0000 | 362,000,000 | 33.33% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 927 | $0.00 | 2,781.0000 | 362,000,000 | 25.00% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 927 | $0.00 | 3,708.0000 | 362,000,000 | 20.00% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 349 | $0.00 | 523.0000 | 362,000,000 | 40.02% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 349 | $0.00 | 872.0000 | 362,000,000 | 28.58% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 349 | $0.00 | 1,221.0000 | 362,000,000 | 22.23% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Non-Qualified Stock Option (right to buy) | 173 | $0.00 | 1,570.0000 | 362,000,000 | 9.93% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 349 | $297.94 | 15,000.0000 | 362,000,000 | 2.27% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 349 | $71.32 | 15,349.0000 | 362,000,000 | 2.33% | 0.00% |
| April 21, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 6000 | $174.26 | 7,950.0000 | 362,000,000 | 307.69% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 349 | $71.32 | 15,349.0000 | 362,000,000 | 2.33% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 349 | $297.93 | 15,000.0000 | 362,000,000 | 2.27% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 349 | $71.32 | 15,349.0000 | 362,000,000 | 2.33% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 173 | $297.89 | 15,000.0000 | 362,000,000 | 1.14% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 173 | $71.32 | 15,173.0000 | 362,000,000 | 1.15% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | S | Common Stock | 463 | $297.89 | 15,000.0000 | 362,000,000 | 2.99% | 0.00% |
| April 21, 2023 | RUBASH MARK J | Director | M | Common Stock | 463 | $90.49 | 15,463.0000 | 362,000,000 | 3.09% | 0.00% |
| April 24, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Non-Qualified Stock Option (right to buy) | 54000 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.01% |
| April 21, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Non-Qualified Stock Option (right to buy) | 54000 | $0.00 | 54,000.0000 | 362,000,000 | 50.00% | 0.01% |
| April 24, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | S | Common Stock | 40764 | $299.20 | 155,712.0000 | 362,000,000 | 20.75% | 0.01% |
| April 24, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 54000 | $42.64 | 196,476.0000 | 362,000,000 | 37.90% | 0.01% |
| April 21, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | S | Common Stock | 40800 | $297.92 | 142,476.0000 | 362,000,000 | 22.26% | 0.01% |
| April 21, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 54000 | $42.64 | 183,276.0000 | 362,000,000 | 41.77% | 0.01% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 849 | $0.00 | 2,851.0000 | 362,000,000 | 42.41% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | A | Restricted Stock Units | 3352 | $0.00 | 3,352.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1003 | $0.00 | 3,007.0000 | 362,000,000 | 25.01% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 2256 | $0.00 | 2,253.0000 | 362,000,000 | 50.03% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | A | Non-Qualified Stock Option (right to buy) | 5028 | $0.00 | 5,028.0000 | 362,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1253 | $228.47 | 1,950.0000 | 362,000,000 | 39.12% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 498 | $229.39 | 3,203.0000 | 362,000,000 | 13.46% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1003 | $0.00 | 3,701.0000 | 362,000,000 | 37.18% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 1003 | $229.39 | 2,698.0000 | 362,000,000 | 27.10% | 0.00% |
| Feb. 28, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 2256 | $0.00 | 3,701.0000 | 362,000,000 | 156.12% | 0.00% |
| Feb. 28, 2023 | DiMartino Michele | See Remarks | A | Non-Qualified Stock Option (right to buy) | 4668 | $0.00 | 4,668.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | DiMartino Michele | See Remarks | A | Restricted Stock Units | 3112 | $0.00 | 3,112.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 2175 | $0.00 | 9,629.0000 | 362,000,000 | 29.18% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | F | Common Stock | 1008 | $229.39 | 8,621.0000 | 362,000,000 | 10.47% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 1504 | $0.00 | 10,125.0000 | 362,000,000 | 17.45% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | F | Common Stock | 697 | $229.39 | 9,428.0000 | 362,000,000 | 6.88% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | A | Non-Qualified Stock Option (right to buy) | 5746 | $0.00 | 5,746.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | A | Restricted Stock Units | 2270 | $0.00 | 2,270.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | A | Restricted Stock Units | 4310 | $0.00 | 4,310.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Restricted Stock Units | 1449 | $0.00 | 1,449.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Restricted Stock Units | 752 | $0.00 | 2,256.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | A | Non-Qualified Stock Option (right to buy) | 6464 | $0.00 | 6,464.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | F | Common Stock | 227 | $229.39 | 20,516.0000 | 362,000,000 | 1.09% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Common Stock | 752 | $0.00 | 20,743.0000 | 362,000,000 | 3.76% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Restricted Stock Units | 2175 | $0.00 | 2,172.0000 | 362,000,000 | 50.03% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Restricted Stock Units | 1504 | $0.00 | 4,511.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 28, 2023 | DeSantis Robert | EVP & Chief Product Officer | A | Restricted Stock Units | 3831 | $0.00 | 3,831.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | LOEB GARY | General Counsel | A | Non-Qualified Stock Option (right to buy) | 1889 | $0.00 | 1,889.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | LOEB GARY | General Counsel | A | Restricted Stock Units | 1259 | $0.00 | 1,259.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 2256 | $0.00 | 125,103.0000 | 362,000,000 | 1.84% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 1119 | $229.39 | 123,984.0000 | 362,000,000 | 0.89% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 1003 | $0.00 | 124,987.0000 | 362,000,000 | 0.81% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 498 | $229.39 | 124,489.0000 | 362,000,000 | 0.40% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | A | Non-Qualified Stock Option (right to buy) | 2873 | $0.00 | 2,873.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 2256 | $0.00 | 2,253.0000 | 362,000,000 | 50.03% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 1003 | $0.00 | 3,007.0000 | 362,000,000 | 25.01% | 0.00% |
| Feb. 28, 2023 | MOHR MARSHALL | Executive VP Global Business S | A | Restricted Stock Units | 5746 | $0.00 | 5,746.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | M | Common Stock | 3864 | $0.00 | 1,266,345.0000 | 362,000,000 | 0.31% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | F | Common Stock | 1916 | $229.39 | 1,264,429.0000 | 362,000,000 | 0.15% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | M | Common Stock | 2507 | $0.00 | 1,266,936.0000 | 362,000,000 | 0.20% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | F | Common Stock | 1243 | $229.39 | 1,265,693.0000 | 362,000,000 | 0.10% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | A | Non-Qualified Stock Option (right to buy) | 15801 | $0.00 | 15,801.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | M | Restricted Stock Units | 3864 | $0.00 | 3,864.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | M | Restricted Stock Units | 2507 | $0.00 | 7,518.0000 | 362,000,000 | 25.01% | 0.00% |
| Feb. 28, 2023 | GUTHART GARY S | President & CEO | A | Restricted Stock Units | 10534 | $0.00 | 10,534.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | M | Common Stock | 1257 | $0.00 | 6,071.0000 | 362,000,000 | 26.11% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | F | Common Stock | 435 | $229.39 | 5,636.0000 | 362,000,000 | 7.17% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | M | Common Stock | 752 | $0.00 | 6,388.0000 | 362,000,000 | 13.34% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | F | Common Stock | 261 | $229.39 | 6,127.0000 | 362,000,000 | 4.09% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 6464 | $0.00 | 6,464.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 1257 | $0.00 | 1,254.0000 | 362,000,000 | 50.06% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 752 | $0.00 | 2,256.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 28, 2023 | Samath Jamie | Chief Financial Officer | A | Restricted Stock Units | 4310 | $0.00 | 4,310.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 2256 | $0.00 | 129,637.0000 | 362,000,000 | 1.77% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | F | Common Stock | 1119 | $229.39 | 128,518.0000 | 362,000,000 | 0.86% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 1504 | $0.00 | 130,022.0000 | 362,000,000 | 1.17% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | F | Common Stock | 746 | $229.39 | 129,276.0000 | 362,000,000 | 0.57% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | A | Non-Qualified Stock Option (right to buy) | 8619 | $0.00 | 8,619.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Restricted Stock Units | 2256 | $0.00 | 2,253.0000 | 362,000,000 | 50.03% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Restricted Stock Units | 1504 | $0.00 | 4,511.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 28, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | A | Restricted Stock Units | 5746 | $0.00 | 5,746.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Common Stock | 1449 | $0.00 | 20,508.0000 | 362,000,000 | 7.60% | 0.00% |
| Feb. 28, 2023 | Charlton Henry L | Senior Vice President & Chief | F | Common Stock | 517 | $229.39 | 19,991.0000 | 362,000,000 | 2.52% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 849 | $0.00 | 849.0000 | 362,000,000 | 50.00% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 468 | $0.00 | 1,404.0000 | 362,000,000 | 25.00% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | A | Non-Qualified Stock Option (right to buy) | 1135 | $0.00 | 1,135.0000 | 362,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 162 | $229.39 | 2,863.0000 | 362,000,000 | 5.36% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 468 | $0.00 | 3,025.0000 | 362,000,000 | 18.30% | 0.00% |
| Feb. 28, 2023 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 294 | $229.39 | 2,557.0000 | 362,000,000 | 10.31% | 0.00% |
| Feb. 26, 2023 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 609 | $0.00 | 2,214.0000 | 362,000,000 | 37.94% | 0.00% |
| Feb. 26, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 1710 | $0.00 | 3,420.0000 | 362,000,000 | 33.33% | 0.00% |
| Feb. 26, 2023 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 848 | $231.05 | 122,847.0000 | 362,000,000 | 0.69% | 0.00% |
| Feb. 26, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 1710 | $0.00 | 123,695.0000 | 362,000,000 | 1.40% | 0.00% |
| Feb. 26, 2023 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 1284 | $0.00 | 2,565.0000 | 362,000,000 | 33.36% | 0.00% |
| Feb. 26, 2023 | Samath Jamie | Chief Financial Officer | F | Common Stock | 445 | $231.05 | 4,814.0000 | 362,000,000 | 8.46% | 0.00% |
| Feb. 26, 2023 | Samath Jamie | Chief Financial Officer | M | Common Stock | 1284 | $0.00 | 5,259.0000 | 362,000,000 | 32.30% | 0.00% |
| Feb. 26, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Restricted Stock Units | 1284 | $0.00 | 2,565.0000 | 362,000,000 | 33.36% | 0.00% |
| Feb. 26, 2023 | Charlton Henry L | Senior Vice President & Chief | F | Common Stock | 387 | $231.05 | 19,059.0000 | 362,000,000 | 1.99% | 0.00% |
| Feb. 26, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Common Stock | 1284 | $0.00 | 19,446.0000 | 362,000,000 | 7.07% | 0.00% |
| Feb. 26, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Restricted Stock Units | 1710 | $0.00 | 3,420.0000 | 362,000,000 | 33.33% | 0.00% |
| Feb. 26, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | F | Common Stock | 848 | $231.05 | 127,381.0000 | 362,000,000 | 0.66% | 0.00% |
| Feb. 26, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 1710 | $0.00 | 128,229.0000 | 362,000,000 | 1.35% | 0.00% |
| Feb. 26, 2023 | GUTHART GARY S | President & CEO | M | Restricted Stock Units | 3030 | $0.00 | 6,060.0000 | 362,000,000 | 33.33% | 0.00% |
| Feb. 26, 2023 | GUTHART GARY S | President & CEO | F | Common Stock | 1449 | $231.05 | 1,262,481.0000 | 362,000,000 | 0.11% | 0.00% |
| Feb. 26, 2023 | GUTHART GARY S | President & CEO | M | Common Stock | 3030 | $0.00 | 1,263,930.0000 | 362,000,000 | 0.24% | 0.00% |
| Feb. 26, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1710 | $0.00 | 3,420.0000 | 362,000,000 | 33.33% | 0.00% |
| Feb. 26, 2023 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 592 | $231.05 | 1,445.0000 | 362,000,000 | 29.06% | 0.00% |
| Feb. 26, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1710 | $0.00 | 2,037.0000 | 362,000,000 | 522.94% | 0.00% |
| Feb. 26, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Restricted Stock Units | 1590 | $0.00 | 3,174.0000 | 362,000,000 | 33.38% | 0.00% |
| Feb. 26, 2023 | DeSantis Robert | EVP & Chief Product Officer | F | Common Stock | 501 | $231.05 | 7,454.0000 | 362,000,000 | 6.30% | 0.00% |
| Feb. 26, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 1590 | $0.00 | 7,955.0000 | 362,000,000 | 24.98% | 0.00% |
| Feb. 26, 2023 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 609 | $0.00 | 1,215.0000 | 362,000,000 | 33.39% | 0.00% |
| Feb. 26, 2023 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 212 | $231.05 | 2,002.0000 | 362,000,000 | 9.58% | 0.00% |
| Feb. 15, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | F | Common Stock | 1116 | $244.77 | 126,519.0000 | 362,000,000 | 0.87% | 0.00% |
| Feb. 15, 2023 | MOHR MARSHALL | Executive VP Global Business S | F | Common Stock | 868 | $244.77 | 121,985.0000 | 362,000,000 | 0.71% | 0.00% |
| Feb. 15, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Restricted Stock Units | 1749 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 15, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 2124 | $0.00 | 9,002.0000 | 362,000,000 | 30.88% | 0.00% |
| Feb. 15, 2023 | DeSantis Robert | EVP & Chief Product Officer | F | Common Stock | 666 | $244.77 | 8,336.0000 | 362,000,000 | 7.40% | 0.00% |
| Feb. 16, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 1971 | $240.77 | 6,365.0000 | 362,000,000 | 23.64% | 0.00% |
| Feb. 15, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Restricted Stock Units | 2124 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 15, 2023 | Samath Jamie | Chief Financial Officer | M | Common Stock | 723 | $0.00 | 4,248.0000 | 362,000,000 | 20.51% | 0.00% |
| Feb. 15, 2023 | Samath Jamie | Chief Financial Officer | F | Common Stock | 273 | $244.77 | 3,975.0000 | 362,000,000 | 6.43% | 0.00% |
| Feb. 15, 2023 | Samath Jamie | Chief Financial Officer | M | Restricted Stock Units | 723 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 15, 2023 | GUTHART GARY S | President & CEO | M | Common Stock | 3750 | $0.00 | 1,262,208.0000 | 362,000,000 | 0.30% | 0.00% |
| Feb. 15, 2023 | GUTHART GARY S | President & CEO | F | Common Stock | 1308 | $244.77 | 1,260,900.0000 | 362,000,000 | 0.10% | 0.00% |
| Feb. 15, 2023 | GUTHART GARY S | President & CEO | M | Restricted Stock Units | 3750 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 15, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 2250 | $0.00 | 127,635.0000 | 362,000,000 | 1.79% | 0.00% |
| Feb. 15, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 1749 | $0.00 | 122,853.0000 | 362,000,000 | 1.44% | 0.00% |
| Feb. 15, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Restricted Stock Units | 1311 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 15, 2023 | Charlton Henry L | Senior Vice President & Chief | F | Common Stock | 413 | $244.77 | 18,162.0000 | 362,000,000 | 2.22% | 0.00% |
| Feb. 15, 2023 | Charlton Henry L | Senior Vice President & Chief | M | Common Stock | 1311 | $0.00 | 18,575.0000 | 362,000,000 | 7.59% | 0.00% |
| Feb. 15, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Restricted Stock Units | 2250 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 15, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Restricted Stock Units | 1749 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 16, 2023 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 116 | $240.77 | 1,605.0000 | 362,000,000 | 6.74% | 0.00% |
| Feb. 15, 2023 | Widman Fredrik | VP Corporate Controller | M | Common Stock | 393 | $0.00 | 1,882.0000 | 362,000,000 | 26.39% | 0.00% |
| Feb. 15, 2023 | Widman Fredrik | VP Corporate Controller | F | Common Stock | 161 | $244.77 | 1,721.0000 | 362,000,000 | 8.55% | 0.00% |
| Feb. 15, 2023 | Widman Fredrik | VP Corporate Controller | M | Restricted Stock Units | 393 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | DiMartino Michele | See Remarks | M | Common Stock | 1504 | $0.00 | 1,901.0000 | 362,000,000 | 378.84% | 0.00% |
| Feb. 10, 2023 | DiMartino Michele | See Remarks | F | Common Stock | 478 | $245.27 | 1,423.0000 | 362,000,000 | 25.14% | 0.00% |
| Feb. 10, 2023 | DiMartino Michele | See Remarks | M | Common Stock | 987 | $0.00 | 2,410.0000 | 362,000,000 | 69.36% | 0.00% |
| Feb. 10, 2023 | DiMartino Michele | See Remarks | F | Common Stock | 298 | $245.27 | 2,112.0000 | 362,000,000 | 12.37% | 0.00% |
| Feb. 10, 2023 | DiMartino Michele | See Remarks | M | Restricted Stock Units | 1504 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | DiMartino Michele | See Remarks | M | Restricted Stock Units | 987 | $0.00 | 2,960.0000 | 362,000,000 | 25.01% | 0.00% |
| Feb. 15, 2023 | Curet Myriam | EVP & Chief Medical Officer | M | Common Stock | 1749 | $0.00 | 2,076.0000 | 362,000,000 | 534.86% | 0.00% |
| Feb. 15, 2023 | Curet Myriam | EVP & Chief Medical Officer | F | Common Stock | 625 | $244.77 | 1,451.0000 | 362,000,000 | 30.11% | 0.00% |
| Feb. 16, 2023 | Curet Myriam | EVP & Chief Medical Officer | S | Common Stock | 1124 | $240.77 | 327.0000 | 362,000,000 | 77.46% | 0.00% |
| Feb. 13, 2023 | Widman Fredrik | VP Corporate Controller | S | Common Stock | 1307 | $246.09 | 1,489.0000 | 362,000,000 | 46.75% | 0.00% |
| Feb. 13, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Common Stock | 54000 | $63.25 | 154,353.0000 | 362,000,000 | 53.81% | 0.01% |
| Feb. 13, 2023 | MOHR MARSHALL | Executive VP Global Business S | S | Common Stock | 33249 | $245.61 | 121,104.0000 | 362,000,000 | 21.54% | 0.01% |
| Feb. 13, 2023 | MOHR MARSHALL | Executive VP Global Business S | M | Non-Qualified Stock Option (right to buy) | 54000 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.01% |
| Feb. 6, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Non-Qualified Stock Option (right to buy) | 54000 | $0.00 | 0.0000 | 362,000,000 | 100.00% | 0.01% |
| Feb. 6, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | S | Common Stock | 45025 | $250.53 | 125,385.0000 | 362,000,000 | 26.42% | 0.01% |
| Feb. 6, 2023 | Rosa David J. | EVP Chief Strategy & Growth Of | M | Common Stock | 54000 | $63.25 | 170,410.0000 | 362,000,000 | 46.39% | 0.01% |
| Jan. 27, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 816 | $250.00 | 6,769.0000 | 362,000,000 | 10.76% | 0.00% |
| Jan. 27, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 816 | $0.00 | 1,269.0000 | 362,000,000 | 39.14% | 0.00% |
| Jan. 27, 2023 | DeSantis Robert | EVP & Chief Product Officer | S | Common Stock | 813 | $250.00 | 6,769.0000 | 362,000,000 | 10.72% | 0.00% |
| Jan. 27, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 816 | $177.99 | 7,585.0000 | 362,000,000 | 12.05% | 0.00% |
| Jan. 27, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Common Stock | 813 | $179.70 | 7,582.0000 | 362,000,000 | 12.01% | 0.00% |
| Jan. 27, 2023 | DeSantis Robert | EVP & Chief Product Officer | M | Non-Qualified Stock Option (right to buy) | 813 | $0.00 | 1,449.0000 | 362,000,000 | 35.94% | 0.00% |